☰

Linnéa Marks - Publications

Affiliations: 
University of Texas at Austin, Austin, Texas, U.S.A. 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

0/457 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2021 Sarma KV, Raman AG, Dhinagar NJ, Priester AM, Harmon S, Sanford T, Mehralivand S, Turkbey B, Marks LS, Raman SS, Speier W, Arnold CW. Harnessing clinical annotations to improve deep learning performance in prostate segmentation. Plos One. 16: e0253829. PMID 34170972 DOI: 10.1371/journal.pone.0253829  0.01
2021 Raman AG, Sarma KV, Raman SS, Priester AM, Mirak SA, Riskin-Jones HH, Dhinagar N, Speier W, Felker E, Sisk AE, Lu D, Kinnaird A, Reiter RE, Marks LS, Arnold CW. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 33908801 DOI: 10.1097/JU.0000000000001832  0.01
2021 Brisbane WG, Natarajan S, Priester A, Felker ER, Kinnaird A, Marks LS. Focal Laser Ablation of Prostate Cancer: An Office Procedure. Journal of Visualized Experiments : Jove. PMID 33871450 DOI: 10.3791/61984  0.01
2021 Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, et al. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urologic Oncology. PMID 33676851 DOI: 10.1016/j.urolonc.2021.01.027  0.01
2021 Sarma KV, Harmon S, Sanford T, Roth HR, Xu Z, Tetreault J, Xu D, Flores MG, Raman AG, Kulkarni R, Wood BJ, Choyke PL, Priester AM, Marks LS, Raman SS, et al. Federated learning improves site performance in multicenter deep learning without data sharing. Journal of the American Medical Informatics Association : Jamia. PMID 33537772 DOI: 10.1093/jamia/ocaa341  0.01
2020 Dhinagar NJ, Speier W, Sarma KV, Raman A, Kinnaird A, Raman SS, Marks LS, Arnold CW. Semi-automated PIRADS scoring via mpMRI analysis. Journal of Medical Imaging (Bellingham, Wash.). 7: 064501. PMID 33392358 DOI: 10.1117/1.JMI.7.6.064501  0.01
2020 Geoghegan R, Priester A, Zhang L, Wu H, Marks L, Natarajan S. Monitoring Focal Laser Ablation with Interstitial Fluence Probes: Monte Carlo Simulation and Phantom Validation. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2020: 5272-5275. PMID 33019173 DOI: 10.1109/EMBC44109.2020.9176370  0.01
2020 Chuang R, Kinnaird A, Kwan L, Sisk A, Barsa D, Felker E, Delfin M, Marks L. Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy. The Journal of Urology. 101097JU000000000000. PMID 32985924 DOI: 10.1097/JU.0000000000001133  0.01
2020 Yamada Y, Ukimura O, Kaneko M, Matsugasumi T, Fujihara A, Vourganti S, Marks L, Sidana A, Klotz L, Salomon G, de la Rosette J. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World Journal of Urology. PMID 32728885 DOI: 10.1007/s00345-020-03366-x  0.01
2020 Connor MJ, Miah S, Jayadevan R, Khoo CC, Eldred-Evans D, Shah T, Ahmed HU, Marks L. Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy. Translational Andrology and Urology. 9: 1501-1509. PMID 32676437 DOI: 10.21037/tau.2019.07.16  0.01
2020 Salami SS, Tosoian JJ, Nallandhighal S, Jones TA, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, ... Marks LS, et al. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. European Urology. PMID 32631746 DOI: 10.1016/J.Eururo.2020.06.041  0.01
2020 Kinnaird A, Sharma V, Chuang R, Priester A, Tran E, Barsa DE, Delfin M, Kwan L, Sisk A, Felker E, Marks LS. Risk of Prostate Cancer after a Negative MRI-Guided Biopsy. The Journal of Urology. 101097JU000000000000. PMID 32614257 DOI: 10.1097/JU.0000000000001232  0.01
2020 Marks LS, Natarajan S. RE: Prostate Cancer Detection Rate of Free-hand versus 3D Template Mapping Biopsy Using an MRI/Ultrasound Fusion Device in Biopsy-Naïve Men. The Journal of Urology. 101097JU000000000000. PMID 32364836 DOI: 10.1097/Ju.0000000000001124  0.01
2020 Al Hussein Al Awamlh B, Marks LS, Sonn GA, Natarajan S, Fan RE, Gross MD, Mauer E, Banerjee S, Hectors S, Carlsson S, Margolis DJ, Hu JC. Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions. Urologic Oncology. PMID 32307327 DOI: 10.1016/J.Urolonc.2020.03.019  0.01
2020 Guorgui J, Kinnaird A, Jayadevan R, Priester AM, Arnold CW, Marks LS. An Electronic Form for Reporting Results of Targeted Prostate Biopsy: Urology Integrated Diagnostic Report (Uro-IDR). Urology. PMID 31978527 DOI: 10.1016/J.Urology.2020.01.015  0.01
2020 Ballon J, Kinnaird A, Jayadevan R, Zhou SR, Barsa DE, Kwan L, Marks LS. Magnetic Resonance Imaging Guided Biopsy to Evaluate Prostate Cancer Severity in African American Men Urology Practice. 7: 538-540. DOI: 10.1097/UPJ.0000000000000124  0.01
2020 Priester* A, Kinnaird A, Delfin M, Barsa D, Sisk A, Marks L. PD57-08 TRACKED BIOPSY DATA IMPROVES PREDICTION OF PROSTATE TUMOR SIZE AND STAGE The Journal of Urology. 203: e1196-e1197. DOI: 10.1097/JU.0000000000000967.08  0.01
2020 Chuang* R, Kinnaird A, Zhou S, Kwan L, Sisk A, Barsa D, Felker E, Delfin M, Marks L. MP70-03 18-MONTH OUTCOMES OF HEMI-GLAND CRYOABLATION OF PROSTATE CANCER EVALUATED BY MRI-GUIDED BIOPSY Journal of Urology. 203. DOI: 10.1097/JU.0000000000000950.03  0.01
2020 Priester A, Kinnaird* A, Zhou S, Jayadevan R, Rappaport M, Delfin M, Sisk A, Felker E, Marks L. MP70-16 FOCAL THERAPY OF PROSTATE CANCER: USE OF TRACKED BIOPSY SITES TO DETERMINE TREATMENT MARGINS Journal of Urology. 203. DOI: 10.1097/ju.0000000000000950.016  0.01
2020 Ballon J, Chuang* R, Kinnaird A, Jayadevan R, Zhou S, Barsa D, Kwan L, Marks L. MP64-10 MRI-GUIDED BIOPSY TO EVALUATE PROSTATE CANCER SEVERITY IN AFRICAN-AMERICAN MEN Journal of Urology. 203. DOI: 10.1097/ju.0000000000000939.010  0.01
2020 Kinnaird* A, Priester A, Chuang R, Barsa D, Delfin M, Sisk A, Felker E, Kwan L, Marks L. MP56-09 A RISK CALCULATOR INCORPORATING MRI-GUIDED BIOPSY DATA TO PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER Journal of Urology. 203. DOI: 10.1097/JU.0000000000000925.09  0.01
2020 Tosoian J, Salami S, Nallandhighal S, Jones T, Brockman S, Elkhoury F, Bazzi S, Plouffe K, Sumida L, Siddiqui J, Liu C, Kunju L, Morgan T, Vince R, Natarajan S, ... Marks L, et al. Mp09-08 Molecular Dissection Of Grade Progression In Men On Active Surveillance For Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000829.08  0.01
2019 Chuang RJ, Marks LS. Targeted and Systematic Biopsy for Diagnosis and Management of Prostate Cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)). PMID 31864796 DOI: 10.1016/j.clon.2019.11.011  0.01
2019 Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, Cabezon E, Margolis DJ, Robinson BD, Hu JC. Reply by Authors. The Journal of Urology. 101097JU000000000000. PMID 31789578 DOI: 10.1097/JU.0000000000000534.02  0.01
2019 Zhou SR, Priester AM, Jayadevan R, Johnson DC, Yang JJ, Ballon J, Natarajan S, Marks LS. Using Spatial Tracking with MRI/Ultrasound-Guided Biopsy to Identify Unilateral Prostate Cancer. Bju International. PMID 31680423 DOI: 10.1111/Bju.14943  0.01
2019 Kinnaird A, Marks LS. Editorial Comment. The Journal of Urology. 10109701JU0000604048. PMID 31618155 DOI: 10.1097/01.JU.0000604048.44926.a2  0.01
2019 Zhou SR, Chang E, Patankar A, Huang J, Marks LS, Natarajan S. Prostate Cancer Detection Rate of Free-hand versus 3D Template Mapping Biopsy Using an MRI/Ultrasound Fusion Device in Biopsy-Naïve Men. The Journal of Urology. 101097JU000000000000. PMID 31596671 DOI: 10.1097/Ju.0000000000000587  0.01
2019 Geoghegan R, Santamaria A, Priester A, Zhang L, Wu H, Grundfest W, Marks L, Natarajan S. A tissue-mimicking prostate phantom for 980 nm laser interstitial thermal therapy. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 36: 993-1002. PMID 31544549 DOI: 10.1080/02656736.2019.1660811  0.01
2019 Jayadevan R, Felker ER, Kwan L, Barsa DE, Zhang H, Sisk AE, Delfin M, Marks LS. Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer. Jama Network Open. 2: e1911019. PMID 31509206 DOI: 10.1001/jamanetworkopen.2019.11019  0.01
2019 Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, Cabezon E, Margolis DJ, Robinson BD, Hu JC. Variation in MRI-Ultrasound Fusion Targeted Biopsy Outcomes in Asian-American Men: A Multi-Center Study. The Journal of Urology. 101097JU000000000000. PMID 31502942 DOI: 10.1097/JU.0000000000000534  0.01
2019 Felker ER, Raman SS, Lu DSK, Tuttle M, Margolis DJ, ElKhoury FF, Sayre J, Marks LS. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation. Ajr. American Journal of Roentgenology. 1-6. PMID 31361529 DOI: 10.2214/AJR.19.21637  0.01
2019 Elkhoury FF, Felker ER, Kwan L, Sisk AE, Delfin M, Natarajan S, Marks LS. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. Jama Surgery. PMID 31188412 DOI: 10.1001/Jamasurg.2019.1734  0.01
2019 Johnson DC, Yang JJ, Kwan L, Barsa DE, Mirak SA, Pooli A, Sadun T, Jayadevan R, Zhou S, Priester AM, Natarajan S, Bajgiran AM, Shakeri S, Sisk A, Felker ER, ... Marks LS, et al. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. PMID 31042322 DOI: 10.1002/Cncr.32170  0.01
2019 Felker ER, Raman SS, Shakeri S, Mirak SA, Bajgiran AM, Kwan L, Khoshnoodi P, ElKhoury FF, Margolis DJA, Karow D, Lu DSK, White N, Marks LS. Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer. Ajr. American Journal of Roentgenology. 1-6. PMID 31039011 DOI: 10.2214/Ajr.18.20836  0.01
2019 Jayadevan R, Zhou S, Priester AM, Delfin M, Marks LS. Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy. Journal of Visualized Experiments : Jove. PMID 31033955 DOI: 10.3791/59231  0.01
2019 Simopoulos DN, Sisk AE, Priester A, Felker ER, Kwan L, Delfin MK, Reiter RE, Marks LS. Cancer Core Length from Targeted Biopsy: An Index of Prostate Cancer Volume and Pathologic Stage. Bju International. PMID 30694605 DOI: 10.1111/bju.14691  0.01
2019 Zhou SR, Simopoulos DN, Jayadevan R, Felker ER, Delfin MK, Barsa DE, Kwan L, Marks LS. USE OF MRI-GUIDED BIOPSY FOR SELECTION AND FOLLOW-UP OF MEN UNDERGOING HEMI-GLAND CRYOABLATION OF PROSTATE CANCER. Urology. PMID 30659903 DOI: 10.1016/j.urology.2018.11.052  0.01
2019 Jayadevan R, Marks LS. Exclusive MRI-targeted biopsy: not so fast. The Lancet. Oncology. 20: 9-10. PMID 30470503 DOI: 10.1016/S1470-2045(18)30607-7  0.01
2019 Tosoian JJ, Salami SS, Nallandhighal S, Jones TA, Plouffe KR, Elkhoury FF, Morgan TM, Liu C, Kunju LP, Montgomery JS, Natarajan S, Sisk A, Tomlins SA, Palapattu GS, Marks LS. Molecular characterization of longitudinally tracked prostate cancer foci in men on active surveillance for low-risk disease. Journal of Clinical Oncology. 37: 56-56. DOI: 10.1200/Jco.2019.37.7_Suppl.56  0.01
2019 Jayadevan* R, Elkhoury F, Felker E, Kwan L, Sisk A, Delfin M, Natarajan S, Marks L. LBA-11 PAIREDCAP TRIAL: PROSPECTIVE ASSESSMENT OF IMAGE REGISTRATION IN DIAGNOSIS OF PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557503.00464.18  0.01
2019 Raman* AG, Sarma KV, Shi W, Zhou S, Priester AM, Natarajan S, Speier W, Raman SS, Marks LS, Arnold CW. PD64-05 A MACHINE LEARNING MODEL FOR PREDICTING CANCER PRESENCE IN PROSTATE BIOPSY TARGETS USING MRI Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557444.38516.4C  0.01
2019 Johnson D, Yang J, Kwan L, Barsa D, Mirak S, Pooli A, Sadun T, Jayadevan R, Zhou S, Priester A, Natarajan S, Sisk A, Felker E, Raman S, Marks L, et al. Mp78-07 Do Contemporary Imaging And Biopsy Techniques Reliably Identify Unilateral Prostate Cancer? Implications For Hemiablation Patient Selection The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557339.24703.E5  0.01
2019 Zhou* S, Priester A, Jayadevan R, Yang J, Johnson D, Raman A, Sarma K, Arnold C, Ballon J, Natarajan S, Marks L. MP78-04 PREDICTING PROSTATE CANCER FOCAL THERAPY ELIGIBILITY WITH MACHINE LEARNING Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557336.01833.27  0.01
2019 Priester* A, Jayadevan R, Rappaport M, Barsa D, Delfin M, Ely F, Natarajan S, Marks L. V08-07 PROSTATE CANCER: USE OF TARGETED BIOPSY INFORMATION FOR PLANNING PARTIAL GLAND ABLATION WITH HIGH-INTENSITY FOCUSED ULTRASOUND Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556787.89680.66  0.01
2019 Jayadevan* R, Barsa D, Zhang H, Kwan L, Zhou S, Priester A, Ballon J, Marks L. MP48-03 TRACKING, TARGETING, AND DE NOVO TUMOR DEVELOPMENT IN MEN UNDERGOING ACTIVE SURVEILLANCE Journal of Urology. 201. DOI: 10.1097/01.JU.0000556473.69506.25  0.01
2019 Awamlh* BAHA, Marks LS, Sonn G, Gross M, Hu J. MP24-17 CAN WE BETTER UNDERSTAND PI-RADS 3 LESIONS AND AVOID UNNECESSARY BIOPSIES? Journal of Urology. 201. DOI: 10.1097/01.JU.0000555642.29067.a4  0.01
2019 Tosoian SS, Nallandhighal S, Jones T, Plouffe K, Elkhoury F, Morgan T, Liu C, Kunju L, Montgomery J, Natarajan S, Sisk A, Tomlins S, Palapattu G, Marks L. Molecular markers of grade progression in longitudinally tracked prostate cancer foci during active surveillance of low risk disease European Urology Supplements. 18: e1735. DOI: 10.1016/s1569-9056(19)31257-6  0.01
2018 Marks LS. Editorial Comment. The Journal of Urology. 200: 1240. PMID 30172886 DOI: 10.1016/j.juro.2018.06.091  0.01
2018 Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urologic Oncology. PMID 30064933 DOI: 10.1016/j.urolonc.2018.06.006  0.01
2018 Priester AM, Wu H, Khoshnoodi P, Schneider D, Zhang Z, Asvadi N, Sisk A, Raman S, Reiter R, Grundfest W, Marks L, Natarajan S. Registration Accuracy of Patient-Specific, 3D Printed Prostate Molds for Correlating Pathology with Magnetic Resonance Imaging. Ieee Transactions On Bio-Medical Engineering. PMID 29993431 DOI: 10.1109/Tbme.2018.2828304  0.01
2018 Marks LS. Editorial Comment. The Journal of Urology. 200: 563. PMID 29913157 DOI: 10.1016/j.juro.2018.03.168  0.01
2018 Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, et al. A 17-gene Genomic Prostate Score assay provides independent information on adverse pathology in the setting of combined mpMRI fusion-targeted and systematic prostate biopsy. The Journal of Urology. PMID 29524506 DOI: 10.1016/J.Juro.2018.03.004  0.01
2018 Marks LS. Editorial Comment. The Journal of Urology. 199: 981-982. PMID 29360445 DOI: 10.1016/j.juro.2017.10.069  0.01
2018 Golan R, Bernstein A, Sedrakyan A, Daskivich TJ, Du DT, Ehdaie B, Fisher B, Gorin MA, Grunberger I, Hunt B, Jiang HH, Kim HL, Marinac-Dabic D, Marks LS, McClure TD, et al. Development of a nationally-representative coordinated registry network for prostate ablation technologies. The Journal of Urology. PMID 29307684 DOI: 10.1016/J.Juro.2017.12.058  0.01
2018 Elkhoury FF, Simopoulos DN, Marks LS. MR-guided biopsy and focal therapy: new options for prostate cancer management. Current Opinion in Urology. 28: 93-101. PMID 29232269 DOI: 10.1097/MOU.0000000000000471  0.01
2018 Simopoulos D, Delfin M, Kwan L, Priester A, Felker E, Sisk Jr A, Marks L. MP30-18 HEMI-GLAND CRYOABLATION OF PROSTATE CANCER: USE OF MRI-GUIDED BIOPSY FOR EVALUATION AND FOLLOW-UP Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.959  0.01
2018 Elkhoury F, Natarajan S, Priester A, Jones T, Geoghegan R, Delfin M, Felker E, Sisk A, Raman S, Pantuck A, Grundfest W, Marks L. MP30-04 MRI-GUIDED BIOPSY FOLLOWING FOCAL LASER ABLATION OF PROSTATE CANCER: SUBSEQUENT OUTCOMES OF 2 CLINICAL TRIALS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.945  0.01
2018 Elkhoury F, Calais J, Czernin J, Fendler W, Herrmann K, Eiber M, Ceci F, Reiter R, Marks L. Mp20-16 68Ga-Psma-11 Pet/Ct Vs 18F-Fluciclovine Pet/Ct: A Case Series In Prostate Cancer Patients With Biochemical Recurrence The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.686  0.01
2018 Simopoulos D, Vandel J, Felker E, Kwan L, Sisk Jr A, Marks L. MP20-05 CLINICAL SIGNIFICANCE OF GRADE 5 LESIONS ON MRI Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.675  0.01
2018 Elkhoury F, Felker E, Kwan L, Raman S, Lu D, Shakeri S, Khoshnoodi P, White N, Karow D, Marks L. MP14-15 RESTRICTION SPECTRUM IMAGING IN PROSTATE CANCER DIAGNOSIS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.508  0.01
2018 Simopoulos D, Sisk A, Priester A, Kwan L, Reiter R, Marks L. PD47-07 TARGETED CANCER CORE LENGTH AND RISK-STRATIFICATION OF PROSTATE CANCER Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.2167  0.01
2018 Priester A, Elkhoury F, Vandel J, Delfin M, Felker E, Natarajan S, Marks L. MP40-02 TARGETED PROSTATE BIOPSY: CANCER EXTENDS BEYOND THE ROI! Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1269  0.01
2018 Elkhoury F, Natarajan S, Kwan L, Felker E, Delfin M, Sisk A, Marks L. PD23-01 TARGETED VS STANDARD PROSTATE BIOPSY: A PROSPECTIVE TRIAL IN BIOPSY-NAIVE MEN Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1182  0.01
2017 Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, Reiter RR, Rettig MB, Marks LS, Ahlering TE, Huynh L, Slavik R, Gupta P, Quon A, Allen-Auerbach MS, et al. Actual impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29242398 DOI: 10.2967/Jnumed.117.202945  0.01
2017 Elkhoury FF, Simopoulos DN, Marks LS. Targeted Prostate Biopsy in the Era of Active Surveillance. Urology. PMID 28962878 DOI: 10.1016/j.urology.2017.09.007  0.01
2017 Felker ER, Raman SS, Margolis DJ, Lu DSK, Shaheen N, Natarajan S, Sharma D, Huang J, Dorey F, Marks LS. Risk Stratification Among Men With Prostate Imaging Reporting and Data System Version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? Ajr. American Journal of Roentgenology. 1-6. PMID 28858541 DOI: 10.2214/Ajr.17.18008  0.01
2017 Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S. Focal therapy eligibility determined by MRI/US fusion biopsy. The Journal of Urology. PMID 28830754 DOI: 10.1016/J.Juro.2017.08.085  0.01
2017 Chang E, Jones TA, Natarajan S, Sharma D, Simopoulos D, Margolis DJ, Huang J, Dorey FJ, Marks LS. Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer. The Journal of Urology. PMID 28728993 DOI: 10.1016/J.Juro.2017.07.038  0.01
2017 Jones TA, Chin J, Mcleod D, Barkin J, Pantuck A, Marks LS. High-Intensity Focused Ultrasound for Radio-recurrent Prostate Cancer: A North American Clinical Trial. The Journal of Urology. PMID 28652121 DOI: 10.1016/j.juro.2017.06.078  0.01
2017 Simopoulos DN, Natarajan S, Jones TA, Fendler WP, Sisk AE, Marks LS. Targeted Prostate Biopsy Using (68)Gallium PSMA-PET/CT for Image Guidance. Urology Case Reports. 14: 11-14. PMID 28607878 DOI: 10.1016/J.Eucr.2017.05.006  0.01
2017 Golan R, Bernstein AN, McClure TD, Sedrakyan A, Patel NA, Parekh DJ, Marks LS, Hu JC. Partial gland treatment of prostate cancer utilizing high-intensity focused ultrasound in the primary and salvage setting: a systematic review. The Journal of Urology. PMID 28433640 DOI: 10.1016/j.juro.2017.03.137  0.01
2017 Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, Felker E, Margolis DJ, Sisk A, Pantuck A, Grundfest W, Marks LS. Focal Laser Ablation of Prostate Cancer: Feasibility of MRI/US Fusion for Guidance. The Journal of Urology. PMID 28396184 DOI: 10.1016/J.Juro.2017.04.017  0.01
2017 Huen KH, Nseyo U, Marks LS. The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education. Urology. 105: 29-32. PMID 28363740 DOI: 10.1016/j.urology.2017.03.031  0.01
2017 Jones TA, Marks LS. Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population. European Urology. PMID 28233592 DOI: 10.1016/j.eururo.2017.02.012  0.01
2017 Marks LS. Editorial Comment. Urology. 102: 195-196. PMID 28034528 DOI: 10.1016/j.urology.2016.10.041  0.01
2017 Salmasi A, Said JW, Raman S, Shindel AW, McCullough D, Bailey H, Rothney M, Marks LS, Febbo PG, Reiter RE. A 17-gene panel for prediction of adverse surgical pathology in the setting of MRI-guided prostate biopsy. Journal of Clinical Oncology. 35: 5063-5063. DOI: 10.1200/Jco.2017.35.15_Suppl.5063  0.01
2017 Jones T, Priester A, Natarajan S, Khoshnoodi P, Grundfest W, Marks L. PNFBA-10 FOCAL THERAPY OF PROSTATE CANCER: DEFINING APPROPRIATE TREATMENT MARGINS USING MRI:WHOLE MOUNT CO-REGISTRATION Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3239  0.01
2017 Marks L, Natarajan S, Priester A, Margolis D. V8-01 FOCAL LASER ABLATION: PATH TO A CLINIC TREATMENT FOR PROSTATE CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2337  0.01
2017 Chang E, Jones T, Margolis D, Huang J, Natarajan S, Sharma D, Delfin M, Dorey F, Marks L. PD28-07 TRACKING OF PRIOR POSITIVE SITES BY MRI/US FUSION IMPROVES DETECTION OF GLEASON SCORE UPGRADING Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1241  0.01
2016 Palapattu GS, Salami SS, Cani AK, Hovelson DH, Lazo de la Vega L, Vandenberg KR, Bratley JV, Liu CJ, Kunju LP, Montgomery JS, Morgan TM, Natarajan S, Huang J, Tomlins SA, Marks LS. Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28031426 DOI: 10.1158/1078-0432.Ccr-16-1454  0.01
2016 Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park SJ, Marks L, Pantuck A, Steinberg M, Kamrava M. High-dose rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer. Brachytherapy. PMID 27965117 DOI: 10.1016/j.brachy.2016.11.002  0.01
2016 Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, Partin AW, Sokoll L, Chan DW, Bangma CH, van Schaik RH, Slawin KM, Marks LS, Catalona WJ. Prostate Health Index (phi) Improves Multivariable Risk Prediction of Aggressive Prostate Cancer. Bju International. PMID 27743489 DOI: 10.1111/Bju.13676  0.01
2016 Jones TA, Natarajan S, Priester AM, Marks LS. Images in Clinical Urology - Focal Laser Ablation of Prostate Cancer. Urology. PMID 27720973 DOI: 10.1016/J.Urology.2016.10.002  0.01
2016 Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdominal Radiology (New York). PMID 27670878 DOI: 10.1007/s00261-016-0920-7  0.01
2016 Nassiri N, Margolis DJ, Natarajan S, Sharma DS, Huang J, Dorey FJ, Marks LS. Targeted biopsy to detect Gleason score upgrading during active surveillance for men with low- vs. intermediate-risk prostate cancer. The Journal of Urology. PMID 27639713 DOI: 10.1016/J.Juro.2016.09.070  0.01
2016 Marks LS. Some prostate cancers are invisible to magnetic resonance imaging! Bju International. 118: 492-3. PMID 27625328 DOI: 10.1111/bju.13440  0.01
2016 Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS. MRI Underestimation of Prostate Cancer Geometry: Use of Patient-Specific Molds to Correlate Images with Whole-Mount Pathology. The Journal of Urology. PMID 27484386 DOI: 10.1016/J.Juro.2016.07.084  0.01
2016 Eckert R, Huberty J, Gowin K, Mesa R, Marks L. Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research. Integrative Cancer Therapies. PMID 27458250 DOI: 10.1177/1534735416661417  0.01
2016 Chera BS, Mazur L, Adams RD, Kim HJ, Milowsky MI, Marks LB. Creating a Culture of Safety Within an Institution: Walking the Walk. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 27328790 DOI: 10.1200/Jop.2016.012864  0.01
2016 Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Prostate MRI and MRI-Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement of the American Urological Association and the Society of Abdominal Radiology's Prostate Cancer Disease-Focused Panel. The Journal of Urology. PMID 27320841 DOI: 10.1016/j.juro.2016.06.079  0.01
2016 Marks LB. Reality Check. International Journal of Radiation Oncology, Biology, Physics. 95: 905-8. PMID 27302505 DOI: 10.1016/j.ijrobp.2015.11.027  0.01
2016 Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, ... ... Marks LB, et al. Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. International Journal of Radiation Oncology, Biology, Physics. 95: 873-9. PMID 27302503 DOI: 10.1016/J.Ijrobp.2016.03.006  0.01
2016 Katanec T, Majstorovic M, Negovetic Vranic D, Ivic Kardum M, Marks LA. New toothpaste to deal with dentine hypersensitivity: double-blind randomized controlled clinical trial. International Journal of Dental Hygiene. PMID 27296170 DOI: 10.1111/idh.12231  0.01
2016 Taneja SS, Bennett J, Coleman J, Grubb R, Andriole G, Reiter RE, Marks L, Azzouzi AR, Emberton M. Final Results of a Phase I/II Multicenter Trial of WST11 (TOOKAD® Soluble) Vascular-Targeted Photodynamic Therapy (VTP) for Hemiablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Conducted in the United States. The Journal of Urology. PMID 27291652 DOI: 10.1016/j.juro.2016.05.113  0.01
2016 Mesko S, Marks L, Ragab O, Patel S, Margolis DA, Demanes DJ, Kamrava M. Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification. American Journal of Clinical Oncology. PMID 27281263 DOI: 10.1097/COC.0000000000000308  0.01
2016 Kaidar-Person O, Kostich M, Zagar TM, Jones E, Gupta G, Mavroidis P, Das SK, Marks LB. Helical tomotherapy for bilateral breast cancer: Clinical experience. Breast (Edinburgh, Scotland). 28: 79-83. PMID 27253152 DOI: 10.1016/J.Breast.2016.05.004  0.01
2016 Jones TA, Radtke JP, Hadaschik B, Marks LS. Optimizing safety and accuracy of prostate biopsy. Current Opinion in Urology. PMID 27214580 DOI: 10.1097/MOU.0000000000000310  0.01
2016 Fields H, Millstine D, Agrwal N, Marks L. Is Meat Killing Us? The Journal of the American Osteopathic Association. 116: 296-300. PMID 27111782 DOI: 10.7556/jaoa.2016.059  0.01
2016 Van den Berghe LI, De Clercq E, Marks LA. Treatment needs and therapy experiences in patients with temporomandibular disorders: a retrospective survey. Cranio : the Journal of Craniomandibular Practice. 1-6. PMID 27077254 DOI: 10.1080/08869634.2016.1159814  0.01
2016 Felker ER, Margolis DJ, Nassiri N, Marks LS. Prostate cancer risk stratification with magnetic resonance imaging. Urologic Oncology. PMID 27040381 DOI: 10.1016/j.urolonc.2016.03.001  0.01
2016 Mazur LM, Mosaly PR, Moore C, Comitz E, Yu F, Falchook AD, Eblan MJ, Hoyle LM, Tracton G, Chera BS, Marks LB. Toward a better understanding of task demands, workload, and performance during physician-computer interactions. Journal of the American Medical Informatics Association : Jamia. PMID 27026617 DOI: 10.1093/Jamia/Ocw016  0.01
2016 Greene CJ, Marks LR, Hu JC, Reddinger R, Mandell L, Roche-Hakansson H, King-Lyons ND, Connell TD, Hakansson AP. A novel strategy to protect against influenza-induced pneumococcal disease without interfering with commensal colonization. Infection and Immunity. PMID 27001538 DOI: 10.1128/Iai.01478-15  0.01
2016 Velasco C, Woods AT, Marks LE, Cheok AD, Spence C. The semantic basis of taste-shape associations. Peerj. 4: e1644. PMID 26966646 DOI: 10.7717/Peerj.1644  0.01
2016 Wang Z, Loon A, Subramanian A, Gerhold S, McDermott EJ, Enterkin J, Hieckel M, Russell BC, Green R, Moewes A, Guo J, Blaha P, Castell MR, Diebold U, Marks LD. Transition from reconstruction towards thin film on the (110) surface of strontium titanate. Nano Letters. PMID 26954064 DOI: 10.1021/Acs.Nanolett.5B05211  0.01
2016 Fernandez C, Descamps I, Fabjanska K, Kaschke I, Marks L. Treatment needs and predictive capacity of explanatory variables of oral disease in young athletes with an intellectual disability in Europe and Eurasia. European Journal of Paediatric Dentistry : Official Journal of European Academy of Paediatric Dentistry. 17: 9-16. PMID 26949233  0.01
2016 Kaidar-Person O, Zagar TM, Ewend M, Tzuk-Shina T, Marks LB. Frameless LINAC-based stereotactic radiation therapy to brain metastasis resection cavity without whole-brain radiation therapy: A systematic review. Practical Radiation Oncology. PMID 26922701 DOI: 10.1016/J.Prro.2016.01.002  0.01
2016 Marks LR, Dodd H, Russo TA, Berenson CS. Burkholderia ginsengisoli bacteraemia: emergence of a novel pathogen. Bmj Case Reports. 2016. PMID 26912763 DOI: 10.1136/bcr-2015-213584  0.01
2016 Tan HJ, Marks LS, Hoyt MA, Kwan L, Filson CP, Macairan M, Lieu P, Litwin MS, Stanton AL. The relationship between intolerance of uncertainty and anxiety in men on active surveillance for prostate cancer. The Journal of Urology. PMID 26872841 DOI: 10.1016/J.Juro.2016.01.108  0.01
2016 Warner A, Dahele M, Hu B, Palma DA, Senan S, Oberije C, Tsujino K, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris L, Ramella S, De Ruyck K, De Dios NR, et al. Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 94: 612-20. PMID 26867890 DOI: 10.1016/j.ijrobp.2015.11.030  0.01
2016 McCarthy MC, DeGraves S, Wakefield CE, Bowden MJ, Marks LV, Williams LK. The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 26857925 DOI: 10.1007/s00520-016-3107-4  0.01
2016 Chera BS, Mazur L, Adams RD, Marks LB. The Promise and Burden of Peer Review in Radiation Oncology. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 26837564 DOI: 10.1200/Jop.2015.008961  0.01
2016 Fields H, Ruddy B, Wallace MR, Shah A, Millstine D, Marks L. How to Monitor and Advise Vegans to Ensure Adequate Nutrient Intake. The Journal of the American Osteopathic Association. 116: 96-9. PMID 26830525 DOI: 10.7556/jaoa.2016.022  0.01
2016 Hallowell ES, Parikh R, Veldhuizen MG, Marks LE. Flavor Identification and Intensity: Effects of Stimulus Context. Chemical Senses. PMID 26830499 DOI: 10.1093/Chemse/Bjv087  0.01
2016 Marks LD, Peng L. Nanoparticle shape, thermodynamics and kinetics. Journal of Physics. Condensed Matter : An Institute of Physics Journal. 28: 053001. PMID 26792459 DOI: 10.1088/0953-8984/28/5/053001  0.01
2016 Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. PMID 26749141 DOI: 10.1002/Cncr.29874  0.01
2016 Velasco C, Woods AT, Marks LE, Cheok AD, Spence C. The semantic basis of taste-shape associations Peerj. 2016. DOI: 10.7717/peerj.1644  0.01
2016 Doran JM, Kraha A, Marks LR, Ameen EJ, El-Ghoroury NH. Graduate debt in psychology: A quantitative analysis Training and Education in Professional Psychology. 10: 3-13. DOI: 10.1037/Tep0000112  0.01
2016 Palapattu G, Cani A, Hoevelson D, Mehra R, Montgomery J, Morgan T, Salami S, Tomlins S, Marks L. 832 Molecular profiling of prostate cancer derived from serial MRI targeted prostate biopsy in men on active surveillance European Urology Supplements. 15: e832. DOI: 10.1016/S1569-9056(16)60834-5  0.01
2016 Chen BR, George C, Lin Y, Hu L, Crosby L, Hu X, Stair PC, Marks LD, Poeppelmeier KR, Van Duyne RP, Bedzyk MJ. Morphology and oxidation state of ALD-grown Pd nanoparticles on TiO2- and SrO-terminated SrTiO3 nanocuboids Surface Science. 648: 291-298. DOI: 10.1016/J.Susc.2015.10.057  0.01
2016 Natarajan S, Huang J, Marks L. MP53-07 CANCER DETECTION RATE OF CONVENTIONAL VS 3D TEMPLATE PROSTATE BIOPSY IN A MRI/US FUSION DEVICE Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.504  0.01
2016 Priester A, Pooria K, Ogawa S, Le J, Garritano J, Radosavcev B, Margolis D, Reiter R, Huang J, Grundfest W, Natarajan S, Marks L. S&T-13 INFORMING FOCAL THERAPY MARGINS THROUGH MRI-PATHOLOGY CORRELATION Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2842  0.01
2016 Palapattu G, Cani A, Hovelson D, Mehra R, Montgomery J, Morgan T, Salami S, Tomlins S, Natarajan S, Marks L. PD08-07 MOLECULAR PROGRESSION OF GLEASON 6 PROSTATE CANCER: TRACKING OF SPECIFIC CLONES BY IMAGE-GUIDED BIOPSY Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2823  0.01
2016 Natarajan S, Raman S, Priester A, Garritano J, Margolis D, Lieu P, Macairan M, Huang J, Grundfest W, Marks L. MP18-11 MR-GUIDED FOCAL LASER ABLATION OF INTERMEDIATE RISK PROSTATE CANCER: PHASE I TRIAL Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2712  0.01
2016 Wu J, Margolis D, Natarajan S, Priester A, Huang J, Macairan ML, Lieu P, Sharma D, Dorey F, Marks L. PD06-05 THE MRI-INVISIBLE PROSTATE CANCER: INCIDENCE AND SIGNIFICANCE Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2625  0.01
2015 Stanko KE, Cherry KE, Ryker KS, Mughal F, Marks LD, Brown JS, Gendusa PF, Sullivan MC, Bruner J, Welsh DA, Su LJ, Jazwinski SM. Looking for the Silver Lining: Benefit Finding after Hurricanes Katrina and Rita in Middle-Aged, Older, and Oldest-Old Adults. Current Psychology (New Brunswick, N.J.). 34: 564-575. PMID 27440961 DOI: 10.1007/S12144-015-9366-2  0.01
2015 Marks LB, Bentel G, Sherouse GW, Spencer DP, Light K. Craniospinal Irradiation for Trilateral Retinoblastoma Following Ocular Irradiation. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 18: 125-8. PMID 27421867 DOI: 10.1016/S0958-3947(06)80006-3  0.01
2015 Marks L. Beyond Service: Equipping Change Agents Through Community Leadership Education. New Directions For Student Leadership. 2015: 17-31. PMID 26895166 DOI: 10.1002/yd.20150  0.01
2015 Rose S, Shah BJ, Onken J, DeCross AJ, Davis MH, Jain R, Kim LS, Persley K, Pfeil SA, Marks LN. Introducing the Gastroenterologist-Accountable Professionalism in Practice (G-APP) pathway: bridging the G-APP-replacing MOC with a model for lifelong learning and accountability. Gastroenterology. 149: 1609-26. PMID 26824093  0.01
2015 Natarajan S, Raman S, Priester AM, Garritano J, Margolis DJ, Lieu P, Macairan ML, Huang J, Grundfest W, Marks LS. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. The Journal of Urology. PMID 26748164 DOI: 10.1016/J.Juro.2015.12.083  0.01
2015 Fernandez C, Declerck D, Dedecker M, Marks L. Treatment needs and impact of oral health screening of athletes with intellectual disability in Belgium. Bmc Oral Health. 15: 170. PMID 26714613 DOI: 10.1186/s12903-015-0157-9  0.01
2015 Felker ER, Wu J, Natarajan S, Margolis DJ, Raman SS, Huang J, Dorey F, Marks LS. Serial MRI in Active Surveillance of Prostate Cancer: Incremental Value. The Journal of Urology. PMID 26674305 DOI: 10.1016/J.Juro.2015.11.055  0.01
2015 Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26644543 DOI: 10.1200/JCO.2015.64.3809  0.01
2015 Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. Ca: a Cancer Journal For Clinicians. PMID 26641959 DOI: 10.3322/caac.21319  0.01
2015 Camporesi S, Marks L. Gene editing: Survey invites opinions. Nature. 527: 446. PMID 26607533 DOI: 10.1038/527446c  0.01
2015 Fernandez Rojas C, Wichrowska-Rymarek K, Pavlic A, Vinereanu A, Fabjanska K, Kaschke I, Marks LA. Oral health needs of athletes with intellectual disability in Eastern Europe: Poland, Romania and Slovenia. International Dental Journal. PMID 26601920 DOI: 10.1111/idj.12205  0.01
2015 Zagar TM, Cardinale DM, Marks LB. Breast cancer therapy-associated cardiovascular disease. Nature Reviews. Clinical Oncology. PMID 26598943 DOI: 10.1038/nrclinonc.2015.171  0.01
2015 Kelsey CR, Das S, Gu L, Dunphy FR, Ready NE, Marks LB. Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 93: 997-1004. PMID 26581138 DOI: 10.1016/J.Ijrobp.2015.09.007  0.01
2015 Satzger I, Marks L, Kerick M, Klages S, Berking C, Herbst R, Völker B, Schacht V, Timmermann B, Gutzmer R. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma. Oncotarget. PMID 26498143 DOI: 10.18632/oncotarget.5634  0.01
2015 Marks LB. "Error Bars" in Medical Imaging: Stealth and Treacherous. Radiology. 277: 318-28. PMID 26492019 DOI: 10.1148/radiol.2015150175  0.01
2015 Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, et al. Technology for Innovation in Radiation Oncology. International Journal of Radiation Oncology, Biology, Physics. 93: 485-92. PMID 26460989 DOI: 10.1016/J.Ijrobp.2015.07.007  0.01
2015 Pfeil SA, Shields HM, Marks LN, Rose S. The American Gastroenterological Association Academy of Educators: Creating a Home for Medical Educators in a National Specialty Organization. Gastroenterology. 149: 1309-14. PMID 26409666 DOI: 10.1053/j.gastro.2015.09.016  0.01
2015 Xu R, Chen CC, Wu L, Scott MC, Theis W, Ophus C, Bartels M, Yang Y, Ramezani-Dakhel H, Sawaya MR, Heinz H, Marks LD, Ercius P, Miao J. Three-dimensional coordinates of individual atoms in materials revealed by electron tomography. Nature Materials. PMID 26390325 DOI: 10.1038/Nmat4426  0.01
2015 Chera BS, Mazur L, Marks LB. Applying Normal Accident Theory to radiation oncology: Failures are normal but patient harm can be prevented. Practical Radiation Oncology. 5: 325-7. PMID 26362707 DOI: 10.1016/J.Prro.2015.07.005  0.01
2015 Marks LB, Pawlicki TA, Hayman JA. Learning to Appreciate Swiss Cheese and Other Industrial Engineering Concepts. Practical Radiation Oncology. 5: 277-81. PMID 26362704 DOI: 10.1016/j.prro.2015.07.004  0.01
2015 Ding K, Gulec A, Johnson AM, Schweitzer NM, Stucky GD, Marks LD, Stair PC. Identification of active sites in CO oxidation and water-gas shift over supported Pt catalysts. Science (New York, N.Y.). PMID 26338796 DOI: 10.1126/Science.Aac6368  0.01
2015 Shepard TG, Veldhuizen MG, Marks LE. Response Times to Gustatory-Olfactory Flavor Mixtures: Role of Congruence. Chemical Senses. 40: 565-75. PMID 26304508 DOI: 10.1093/Chemse/Bjv042  0.01
2015 Marks L, Hunter DJ, Scalabrini S, Gray J, McCafferty S, Payne N, Peckham S, Salway S, Thokala P. The return of public health to local government in England: changing the parameters of the public health prioritization debate? Public Health. 129: 1194-203. PMID 26298589 DOI: 10.1016/j.puhe.2015.07.028  0.01
2015 Rose S, Shah BJ, Onken J, DeCross AJ, Davis MH, Jain R, Kim LS, Persley K, Pfeil SA, Marks LN. Bridging the G-APP: Continuous Professional Development for Gastroenterologists: Replacing MOC with a Model for Lifelong Learning and Accountability. Gastroenterology. PMID 26297970 DOI: 10.1053/j.gastro.2015.08.009  0.01
2015 Rose S, Shah BJ, Onken J, DeCross AJ, Davis MH, Jain R, Kim LS, Persley K, Pfeil SA, Marks LN. Bridging the G-APP: Continuous Professional Development for Gastroenterologists: Replacing MOC with a Model for Lifelong Learning and Accountability. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26297857 DOI: 10.1016/j.cgh.2015.08.016  0.01
2015 Bockholt N, Marks LS. Targeted prostate biopsy using magnetic resonance imaging-ultrasound fusion. Asian Journal of Andrology. 17: 870-3. PMID 26289396 DOI: 10.4103/1008-682X.151389  0.01
2015 Hegger I, Marks LK, Janssen SW, Schuit AJ, van Oers HA. Enhancing the contribution of research to health care policy-making: a case study of the Dutch Health Care Performance Report. Journal of Health Services Research & Policy. PMID 26282364 DOI: 10.1177/1355819615599565  0.01
2015 Peng L, Van Duyne RP, Marks LD. Strain-Induced Segregation in Bimetallic Multiply Twinned Particles. The Journal of Physical Chemistry Letters. 6: 1930-4. PMID 26263272 DOI: 10.1021/Acs.Jpclett.5B00706  0.01
2015 Marks L, Fernandez C, Kaschke I, Perlman S. Oral cleanliness and gingival health among Special Olympics athletes in Europe and Eurasia. Medicina Oral, Patología Oral Y Cirugía Bucal. 20: e591-7. PMID 26241452 DOI: 10.4317/medoral.20396  0.01
2015 Lin Y, Wu Z, Wen J, Ding K, Yang X, Poeppelmeier KR, Marks LD. Adhesion and Atomic Structures of Gold on Ceria Nanostructures: The Role of Surface Structure and Oxidation State of Ceria Supports. Nano Letters. 15: 5375-81. PMID 26222267 DOI: 10.1021/Acs.Nanolett.5B02694  0.01
2015 Rakow-Penner RA, White NS, Margolis DJ, Parsons JK, Schenker-Ahmed N, Kuperman JM, Bartsch H, Choi HW, Bradley WG, Shabaik A, Huang J, Liss MA, Marks L, Kane CJ, Reiter RE, et al. Prostate Diffusion Imaging with Distortion Correction. Magnetic Resonance Imaging. PMID 26220859 DOI: 10.1016/J.Mri.2015.07.006  0.01
2015 Tang X, Cullip T, Dooley J, Zagar T, Jones E, Chang S, Zhu X, Lian J, Marks L. Dosimetric effect due to the motion during deep inspiration breath hold for left-sided breast cancer radiotherapy. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 16: 5358. PMID 26219001  0.01
2015 Marks LD, Chiaramonti AN, Rahman SU, Castell MR. Transition from Order to Configurational Disorder for Surface Reconstructions on SrTiO_{3}(111). Physical Review Letters. 114: 226101. PMID 26196629 DOI: 10.1103/Physrevlett.114.226101  0.01
2015 Chera BS, Mazur L, Buchanan I, Kim HJ, Rockwell J, Milowsky MI, Marks LB. Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident Theory. Jama Oncology. 1: 958-64. PMID 26182183 DOI: 10.1001/Jamaoncol.2015.0891  0.01
2015 Nassiri N, Natarajan S, Margolis DJ, Marks LS. Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. Urology. PMID 26166671 DOI: 10.1016/J.Urology.2015.07.001  0.01
2015 Descamps I, Marks LA. Oral health in children with Down syndrome: Parents' views on dental care in Flanders (Belgium). European Journal of Paediatric Dentistry : Official Journal of European Academy of Paediatric Dentistry. 16: 143-8. PMID 26147822  0.01
2015 Mazur L, Chera B, Mosaly P, Taylor K, Tracton G, Johnson K, Comitz E, Adams R, Pooya P, Ivy J, Rockwell J, Marks LB. The association between event learning and continuous quality improvement programs and culture of patient safety. Practical Radiation Oncology. PMID 26127007 DOI: 10.1016/J.Prro.2015.04.010  0.01
2015 Prior H, Marks L, Grant C, South M. Incorporation of capillary microsampling into whole body plethysmography and modified Irwin safety pharmacology studies in rats. Regulatory Toxicology and Pharmacology : Rtp. 73: 19-26. PMID 26111604 DOI: 10.1016/j.yrtph.2015.06.002  0.01
2015 Al-Saffar A, Nogueira da Costa A, Delaunois A, Leishman DJ, Marks L, Rosseels ML, Valentin JP. Gastrointestinal Safety Pharmacology in Drug Discovery and Development. Handbook of Experimental Pharmacology. 229: 291-321. PMID 26091645 DOI: 10.1007/978-3-662-46943-9_12  0.01
2015 Wimmer MA, Laurent MP, Mathew MT, Nagelli C, Liao Y, Marks LD, Jacobs JJ, Fischer A. The effect of contact load on CoCrMo wear and the formation and retention of tribofilms. Wear : An International Journal On the Science and Technology of Friction Lubrication and Wear. 332: 643-649. PMID 26085697 DOI: 10.1016/J.Wear.2015.02.013  0.01
2015 Ciston J, Brown HG, D'Alfonso AJ, Koirala P, Ophus C, Lin Y, Suzuki Y, Inada H, Zhu Y, Allen LJ, Marks LD. Surface determination through atomically resolved secondary-electron imaging. Nature Communications. 6: 7358. PMID 26082275 DOI: 10.1038/Ncomms8358  0.01
2015 Kamrava M, Kishan AU, Margolis DJ, Huang J, Dorey F, Lieu P, Kupelian PA, Marks LS. Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. Practical Radiation Oncology. PMID 26059510 DOI: 10.1016/j.prro.2015.04.006  0.01
2015 Peng L, Ringe E, Van Duyne RP, Marks LD. Segregation in bimetallic nanoparticles. Physical Chemistry Chemical Physics : Pccp. PMID 25971411 DOI: 10.1039/C5Cp01492A  0.01
2015 Filson CP, Marks LS, Litwin MS. Expectant management for men with early stage prostate cancer. Ca: a Cancer Journal For Clinicians. 65: 264-82. PMID 25958817 DOI: 10.3322/caac.21278  0.01
2015 Payne DJ, Miller LF, Findlay D, Anderson J, Marks L. Time for a change: addressing R&D and commercialization challenges for antibacterials. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 370: 20140086. PMID 25918443 DOI: 10.1098/rstb.2014.0086  0.01
2015 Marks LS. Significance of Change in Gleason Grade in Patients on Active Surveillance for Prostate Cancer. The Journal of Urology. 194: 8-9. PMID 25892137 DOI: 10.1016/j.juro.2015.04.069  0.01
2015 Taplin SH, Weaver S, Chollette V, Marks LB, Jacobs A, Schiff G, Stricker CT, Bruinooge SS, Salas E. Teams and teamwork during a cancer diagnosis: interdependency within and between teams. Journal of Oncology Practice / American Society of Clinical Oncology. 11: 231-8. PMID 25873059 DOI: 10.1200/Jop.2014.003376  0.01
2015 Rodrigues G, Oberije C, Senan S, Tsujino K, Wiersma T, Moreno-Jimenez M, Kim TH, Marks LB, Rengan R, De Petris L, Ramella S, DeRuyck K, De Dios NR, Warner A, Bradley JD, et al. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis. International Journal of Radiation Oncology, Biology, Physics. 91: 133-9. PMID 25835622 DOI: 10.1016/j.ijrobp.2014.09.033  0.01
2015 Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, et al. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens. Frontiers in Oncology. 5: 30. PMID 25741473 DOI: 10.3389/Fonc.2015.00030  0.01
2015 Kaplan AL, Ehrlich RM, Marks LS, Walsh PC, Bloom DA, Hu JC. Joseph J. Kaufman: renaissance man. Urology. 85: 487-90. PMID 25733256 DOI: 10.1016/j.urology.2014.10.039  0.01
2015 Kamrava M, Hegde JV, Abgaryan N, Chang E, Le JD, Wang J, Kupelian PA, Marks LS. Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists? Bju International. PMID 25684394 DOI: 10.1111/Bju.13082  0.01
2015 Fernandez C, Kaschke I, Perlman S, Koehler B, Marks L. A multicenter study on dental trauma in permanent incisors among Special Olympics athletes in Europe and Eurasia. Clinical Oral Investigations. PMID 25600092 DOI: 10.1007/s00784-015-1403-x  0.01
2015 Rakow-Penner RA, White NS, Parsons JK, Choi HW, Liss MA, Kuperman JM, Schenker-Ahmed N, Bartsch H, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks L, et al. Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension. Prostate Cancer and Prostatic Diseases. 18: 81-5. PMID 25559097 DOI: 10.1038/Pcan.2014.50  0.01
2015 Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS, van Schaik RH, Chan DW, Sokoll LJ, Cruz AB, Mizrahi IA, et al. The prostate health index selectively identifies clinically significant prostate cancer. The Journal of Urology. 193: 1163-9. PMID 25463993 DOI: 10.1016/J.Juro.2014.10.121  0.01
2015 Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. European Urology. 68: 8-19. PMID 25454618 DOI: 10.1016/j.eururo.2014.10.026  0.01
2015 Hoopes DJ, Johnstone PA, Chapin PS, Kabban CM, Lee WR, Chen AB, Fraass BA, Skinner WJ, Marks LB. Practice patterns for peer review in radiation oncology. Practical Radiation Oncology. 5: 32-8. PMID 25413419 DOI: 10.1016/J.Prro.2014.04.004  0.01
2015 Pepek JM, Marks LB, Berry MF, Ready NE, Gee NG, Coleman RE, D'Amico TA, Crawford J, Kelsey CR. Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy. Practical Radiation Oncology. 5: 79-84. PMID 25413417 DOI: 10.1016/j.prro.2014.05.002  0.01
2015 Mosaly PR, Mazur L, Miller S, Eblan M, Falchook A, Goldin G, Burkhart K, LaChapell D, Adams R, Chera B, Marks LB. Application of human factors analysis and classification system model to event analysis in radiation oncology. Practical Radiation Oncology. 5: 113-9. PMID 25413409 DOI: 10.1016/J.Prro.2014.05.010  0.01
2015 Waddle MR, Chen RC, Arastu NH, Green RL, Jackson M, Qaqish BF, Camporeale J, Collichio FA, Marks LB. Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factors. Practical Radiation Oncology. 5: e245-53. PMID 25413398 DOI: 10.1016/J.Prro.2014.08.004  0.01
2015 Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ, Raman SS, Reiter RE. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. European Urology. 67: 569-76. PMID 25257029 DOI: 10.1016/J.Eururo.2014.08.079  0.01
2015 Hu L, Wang C, Kennedy RM, Marks LD, Poeppelmeier KR. The role of oleic acid: from synthesis to assembly of perovskite nanocuboid two-dimensional arrays. Inorganic Chemistry. 54: 740-5. PMID 25153152 DOI: 10.1021/Ic5011715  0.01
2015 Cherry KE, Sampson L, Nezat PF, Cacamo A, Marks LD, Galea S. Long-term psychological outcomes in older adults after disaster: relationships to religiosity and social support. Aging & Mental Health. 19: 430-43. PMID 25078872 DOI: 10.1080/13607863.2014.941325  0.01
2015 Lin Y, Wen J, Hu L, McCarthy JA, Wang S, Poeppelmeier KR, Marks LD. Electron-induced Ti-rich surface segregation on SrTiO3 nanoparticles. Micron (Oxford, England : 1993). 68: 152-7. PMID 24931386 DOI: 10.1016/J.Micron.2014.05.007  0.01
2015 Marks LU. What can a body do? Answers from Trablus, Cairo, Beirut and Algiers Paragraph. 38: 118-135. DOI: 10.3366/para.2015.0150  0.01
2015 Marks L. Last deglaciation of northern continental Europe | La última deglaciación en la Europa continental septentrional Cuadernos De Investigacion Geografica. 41: 279-293. DOI: 10.18172/cig.2698  0.01
2015 Marks L. Let me tell you, this happened when history, time and landscape in legends from Slavonija | Znaš, bilo je to…. Povijest, vrijeme i krajolik u predajama iz Slavonije Narodna Umjetnost. 52: 195-213. DOI: 10.15176/vol52no210  0.01
2015 Palapattu GS, Cani AK, Huang J, Hovelson DH, Lu D, Margolis D, Natarajan S, Mehra R, Montgomery JS, Morgan TM, Tomlins SA, Marks LS. Progression of low- to high-grade prostate cancer: Molecular profiling of tissue obtained by serial targeted biopsy. Journal of Clinical Oncology. 33: 5017-5017. DOI: 10.1200/Jco.2015.33.15_Suppl.5017  0.01
2015 Tate KA, Fouad NA, Marks LR, Young G, Guzman E, Williams EG. Underrepresented First-Generation, Low-Income College Students’ Pursuit of a Graduate Education: Investigating the Influence of Self-Efficacy, Coping Efficacy, and Family Influence Journal of Career Assessment. 23: 427-441. DOI: 10.1177/1069072714547498  0.01
2015 Marks LH. A strangely mingled monster: Gender and spatial transgression in the hardcore metropolis of Paul Thomas's Jekyll and Hyde Neo-Victorian Cities: Reassessing Urban Politics and Poetics. 4: 249-281. DOI: 10.1163/9789004292338_011  0.01
2015 Marks LD, Chiaramonti AN, Rahman SU, Castell MR. Transition from order to configurational disorder for surface reconstructions on SrTiO3 (111) Physical Review Letters. 114. DOI: 10.1103/PhysRevLett.114.226101  0.01
2015 Jackson M, Marks L. Improving the effectiveness of feedback by use of assessed reflections and withholding of grades Assessment and Evaluation in Higher Education. DOI: 10.1080/02602938.2015.1030588  0.01
2015 Gao Z, Zenou VY, Kennouche D, Marks L, Barnett SA. Solid oxide cells with zirconia/ceria Bi-Layer electrolytes fabricated by reduced temperature firing Journal of Materials Chemistry A. 3: 9955-9964. DOI: 10.1039/C5Ta01964H  0.01
2015 Peng L, Van Duyne RP, Marks LD. Strain-Induced Segregation in Bimetallic Multiply Twinned Particles Journal of Physical Chemistry Letters. 6: 1930-1934. DOI: 10.1021/acs.jpclett.5b00706  0.01
2015 Alpay D, Peng L, Marks LD. Are Nanoparticle Corners Round? Journal of Physical Chemistry C. 119: 21018-21023. DOI: 10.1021/Acs.Jpcc.5B07021  0.01
2015 Kienzle D, Koirala P, Marks LD. Lanthanum aluminate (110) 3 × 1 surface reconstruction Surface Science. 633: 60-67. DOI: 10.1016/J.Susc.2014.11.016  0.01
2015 Marks L, Gałazka D, Woronko B. Climate, environment and stratigraphy of the last Pleistocene glacial stage in Poland Quaternary International. DOI: 10.1016/j.quaint.2015.07.047  0.01
2015 Lindner L, Marks L. Early and Middle Pleistocene fluvial series in northern foreland of the Carpathians (Poland and Ukraine) and their relation to Dnistr River terraces Quaternary International. 357: 22-32. DOI: 10.1016/j.quaint.2014.09.053  0.01
2015 Nseyo U, Marks L. FRI-01 LIGHTS, CAMERA, ACTION: WIRT DAKIN AND THE INTRODUCTION OF FILM AS A UROLOGIC TRAINING TOOL Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.479  0.01
2015 Filson C, Margolis D, Huang J, Natarajan S, Lieu P, Dorey F, Marks L. MP11-05 MR-US FUSION BIOPSY: IMPORTANCE OF BOTH SYSTEMATIC AND TARGETED SAMPLING TO DIAGNOSE PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.386  0.01
2015 Filson C, Margolis D, Huang J, Natarajan S, Lieu P, Dorey F, Marks L. MP60-11 SHOULD A NORMAL MULTIPARAMETRIC MRI PRECLUDE PROSTATE BIOPSY? Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2213  0.01
2015 Filson C, Margolis D, Huang J, Natarajan S, Lieu P, Dorey F, Reiter R, Marks L. PD30-01 MR-US FUSION BIOPSY TO DIAGNOSE PROSTATE CANCER: FIRST 1000 MEN AT UCLA Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1822  0.01
2015 Tan H, Marks LS, Hoyt M, Kwan L, Filson CP, Macairan M, Lieu P, Litwin MS, Stanton AL. Mp27-15 Intolerance Of Uncertainty And Urinary Symptoms Predict Anxiety For Men On Active Surveillance For Low-Risk Prostate Cancer The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1177  0.01
2015 Campbell C, Marks LJ. Good native advertising isn't a secret Business Horizons. DOI: 10.1016/j.bushor.2015.06.003  0.01
2015 Lin Y, McCarthy JA, Poeppelmeier KR, Marks LD. Applications of Electron Microscopy in Heterogeneous Catalysis Catalysis by Materials With Well-Defined Structures. 193-238. DOI: 10.1016/B978-0-12-801217-8.00007-4  0.01
2015 Cherry KE, Lyon BA, Marks LD, Nezat PF, Adamek R, Walsh SD, Fitzgerald KB, Anbinder DR, Bernacchio CV. After the BP Deepwater Horizon Oil Spill: Financial and Health Concerns Among Coastal Residents and Commercial Fishers Current Psychology. 34: 576-586. DOI: 10.1007/S12144-015-9372-4  0.01
2015 Stanko KE, Cherry KE, Ryker KS, Mughal F, Marks LD, Brown JS, Gendusa PF, Sullivan MC, Bruner J, Welsh DA, Su LJ, Jazwinski SM, For The Louisiana Healthy Aging Study. Looking for the Silver Lining: Benefit Finding After Hurricanes Katrina and Rita in Middle-Aged, Older, and Oldest-Old Adults Current Psychology. DOI: 10.1007/s12144-015-9366-2  0.01
2015 Marks LD. A Pragmatic, Step-by-Step Guide for Qualitative Methods: Capturing the Disaster and Long-Term Recovery Stories of Katrina and Rita Current Psychology. 34: 494-505. DOI: 10.1007/S12144-015-9342-X  0.01
2015 Liao Y, Marks LD. Direct Observation of Layer-by-Layer Wear Tribology Letters. 59. DOI: 10.1007/S11249-015-0567-5  0.01
2015 Casillas G, Liao Y, Jose-Yacaman M, Marks LD. Monolayer Transfer Layers During Sliding at the Atomic Scale Tribology Letters. 59: 1-5. DOI: 10.1007/S11249-015-0563-9  0.01
2015 Liao Y, Hoffman E, Marks LD. Nanoscale abrasive wear of CoCrMo in in situ TEM sliding Tribology Letters. 57. DOI: 10.1007/S11249-015-0471-Z  0.01
2015 Lyon BA, Nezat PF, Cherry KE, Marks LD. When multiple disasters strike: Louisiana fishers in the aftermath of hurricanes and the british petroleum deepwater horizon oil spill Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 57-70. DOI: 10.1007/978-3-319-18866-9_4  0.01
2015 Hatch TG, Cherry KE, Lu Y, Marks LD. Seeing silver linings after catastrophic loss: Personal growth, positive adaption, and relationships that matter Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 389-402. DOI: 10.1007/978-3-319-18866-9_21  0.01
2015 Marks LD, Lu Y, Cherry KE, Hatch TG. Faith and coping: Spiritual beliefs and religious practices after hurricanes katrina and rita Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 369-387. DOI: 10.1007/978-3-319-18866-9_20  0.01
2015 Cherry KE, Marks LD, Adamek R, Lyon BA. Younger and older coastal fishers face catastrophic loss after hurricane katrina Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 327-348. DOI: 10.1007/978-3-319-18866-9_18  0.01
2015 Marks LD, Hatch TG, Lu Y, Cherry KE. Families and faith-based communities after a disaster: Successes and failures in the wakes of hurricanes katrina and rita Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 247-2710. DOI: 10.1007/978-3-319-18866-9_14  0.01
2015 Hatch TG, Cherry KE, Kytola KL, Lu Y, Marks LD. Loss, chaos, survival, and despair: The storm after the storms Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 233-245. DOI: 10.1007/978-3-319-18866-9_13  0.01
2015 Kytola KL, Cherry KE, Marks LD, Hatch TG. When neighborhoods are destroyed by disaster: Relocate or return and rebuild? Traumatic Stress and Long-Term Recovery: Coping With Disasters and Other Negative Life Events. 211-229. DOI: 10.1007/978-3-319-18866-9_12  0.01
2015 Marshall MSJ, Becerra-Toledo AE, Marks LD, Castell MR. Defects on strontium titanate Springer Series in Surface Sciences. 58: 327-349. DOI: 10.1007/978-3-319-14367-5_11  0.01
2015 Marks LV. The lock and key of medicine: Monoclonal antibodies and the transformation of healthcare The Lock and Key of Medicine: Monoclonal Antibodies and the Transformation of Healthcare. 1-316.  0.01
2014 Chao Y, Marks LR, Pettigrew MM, Hakansson AP. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Frontiers in Cellular and Infection Microbiology. 4: 194. PMID 25629011 DOI: 10.3389/Fcimb.2014.00194  0.01
2014 Tanboga I, Durhan MA, Durmus B, Marks LA. Temporomandibular disorders in young people with an intellectual disability: prevalence of signs and symptoms. European Journal of Paediatric Dentistry : Official Journal of European Academy of Paediatric Dentistry. 15: 349-54. PMID 25517578  0.01
2014 Marks L. Monoclonal antibodies and the transformation of blood typing. Mabs. 6: 1362-7. PMID 25484059 DOI: 10.4161/mabs.36209  0.01
2014 Marks L, Shankar H. Missed diagnosis of Sturge-Weber syndrome: sequelae in adulthood. Australian Family Physician. 43: 787-8. PMID 25393465  0.01
2014 Priester A, Natarajan S, Le JD, Garritano J, Radosavcev B, Grundfest W, Margolis DJ, Marks LS, Huang J. A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds. American Journal of Clinical and Experimental Urology. 2: 127-35. PMID 25374914  0.01
2014 White NS, McDonald C, McDonald CR, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, ... ... Marks L, et al. Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Research. 74: 4638-52. PMID 25183788 DOI: 10.1158/0008-5472.Can-13-3534  0.01
2014 Pettigrew MM, Marks LR, Kong Y, Gent JF, Roche-Hakansson H, Hakansson AP. Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Infection and Immunity. 82: 4607-19. PMID 25135685 DOI: 10.1128/Iai.02225-14  0.01
2014 Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urologic Oncology. 32: 952-7. PMID 25027689 DOI: 10.1016/J.Urolonc.2014.04.003  0.01
2014 Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. International Journal of Radiation Oncology, Biology, Physics. 89: 626-32. PMID 24929168 DOI: 10.1016/J.Ijrobp.2014.03.022  0.01
2014 Chera BS, Mazur L, Jackson M, Taylor K, Mosaly P, Chang S, Deschesne K, LaChapelle D, Hoyle L, Saponaro P, Rockwell J, Adams R, Marks LB. Quantification of the impact of multifaceted initiatives intended to improve operational efficiency and the safety culture: a case study from an academic medical center radiation oncology department. Practical Radiation Oncology. 4: e101-8. PMID 24890355 DOI: 10.1016/J.Prro.2013.05.007  0.01
2014 Mazur LM, Mosaly PR, Hoyle LM, Jones EL, Chera BS, Marks LB. Relating physician's workload with errors during radiation therapy planning. Practical Radiation Oncology. 4: 71-5. PMID 24890346 DOI: 10.1016/J.Prro.2013.05.010  0.01
2014 Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. The Journal of Urology. 192: 1367-73. PMID 24793118 DOI: 10.1016/J.Juro.2014.04.094  0.01
2014 Chughtai B, Dunphy C, Lee R, Lee D, Sheth S, Marks L, Kaplan SA, Te AE. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia. The Canadian Journal of Urology. 21: 7217-21. PMID 24775575  0.01
2014 Tang X, Zagar TM, Bair E, Jones EL, Fried D, Zhang L, Tracton G, Xu Z, Leach T, Chang S, Marks LB. Clinical experience with 3-dimensional surface matching-based deep inspiration breath hold for left-sided breast cancer radiation therapy. Practical Radiation Oncology. 4: e151-8. PMID 24766689 DOI: 10.1016/j.prro.2013.05.004  0.01
2014 Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. The Journal of Urology. 192: 1081-7. PMID 24747657 DOI: 10.1016/J.Juro.2014.04.013  0.01
2014 Stephenson SK, Chang EK, Marks LS. Screening and detection advances in magnetic resonance image-guided prostate biopsy. The Urologic Clinics of North America. 41: 315-26. PMID 24725492 DOI: 10.1016/j.ucl.2014.01.007  0.01
2014 Clementi EA, Marks LR, Roche-HÃ¥kansson H, HÃ¥kansson AP. Monitoring changes in membrane polarity, membrane integrity, and intracellular ion concentrations in Streptococcus pneumoniae using fluorescent dyes. Journal of Visualized Experiments : Jove. e51008. PMID 24637356 DOI: 10.3791/51008  0.01
2014 Marks LS. Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression. Bju International. 113: E13-4. PMID 24629086 DOI: 10.1111/bju.12306  0.01
2014 Roof K, Marks LB. Breast intensity modulated radiation therapy versus tissue compensation: what's in a name? Practical Radiation Oncology. 4: 3-5. PMID 24621416 DOI: 10.1016/j.prro.2013.02.010  0.01
2014 Perez BA, Mettu P, Vajzovic L, Rivera D, Alkaissi A, Steffey BA, Cai J, Stinnett S, Dutton JJ, Buckley EG, Halperin E, Marks LB, Mruthyunjaya P, Kirsch DG. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes. International Journal of Radiation Oncology, Biology, Physics. 89: 127-36. PMID 24613808 DOI: 10.1016/j.ijrobp.2014.01.026  0.01
2014 Le JD, Huang J, Marks LS. Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer. Asian Journal of Andrology. 16: 522-9. PMID 24589455 DOI: 10.4103/1008-682X.122864  0.01
2014 Marks L. Creative surrender: a Milnerian view of works by Y. Z. Kami. The International Journal of Psycho-Analysis. 95: 67-81. PMID 24571277 DOI: 10.1111/1745-8315.12098  0.01
2014 Hu JC, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Sonn G, Dorey FJ, Marks LS. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? The Journal of Urology. 192: 385-90. PMID 24512956 DOI: 10.1016/J.Juro.2014.02.005  0.01
2014 Marks LR, Mashburn-Warren L, Federle MJ, Hakansson AP. Streptococcus pyogenes biofilm growth in vitro and in vivo and its role in colonization, virulence, and genetic exchange. The Journal of Infectious Diseases. 210: 25-34. PMID 24465015 DOI: 10.1093/Infdis/Jiu058  0.01
2014 Kaplan AL, Trinh QD, Sun M, Carter SC, Nguyen PL, Shih YC, Marks LS, Hu JC. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. The Journal of Sexual Medicine. 11: 1063-70. PMID 24443943 DOI: 10.1111/jsm.12429  0.01
2014 van den Berg MJ, Kringos DS, Marks LK, Klazinga NS. The Dutch Health Care Performance Report: seven years of health care performance assessment in the Netherlands. Health Research Policy and Systems / Biomed Central. 12: 1. PMID 24405849 DOI: 10.1186/1478-4505-12-1  0.01
2014 Marks LB, Prosnitz LR. Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 491-3. PMID 24378409 DOI: 10.1200/JCO.2013.51.3523  0.01
2014 Panigrahi P, Liao Y, Mathew MT, Fischer A, Wimmer MA, Jacobs JJ, Marks LD. Intergranular pitting corrosion of CoCrMo biomedical implant alloy. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 102: 850-9. PMID 24376124 DOI: 10.1002/Jbm.B.33067  0.01
2014 Marks LR, Reddinger RM, Hakansson AP. Biofilm formation enhances fomite survival of Streptococcus pneumoniae and Streptococcus pyogenes. Infection and Immunity. 82: 1141-6. PMID 24371220 DOI: 10.1128/Iai.01310-13  0.01
2014 Eitan Z, Schupak A, Gotler A, Marks LE. Lower pitch is larger, yet falling pitches shrink. Experimental Psychology. 61: 273-84. PMID 24351984 DOI: 10.1027/1618-3169/A000246  0.01
2014 Chino J, Doyle S, Marks LB. The anatomy of radiation oncology residency training. International Journal of Radiation Oncology, Biology, Physics. 88: 3-4. PMID 24331647 DOI: 10.1016/J.Ijrobp.2013.09.039  0.01
2014 Lin Y, Wu Z, Wen J, Poeppelmeier KR, Marks LD. Imaging the atomic surface structures of CeO2 nanoparticles. Nano Letters. 14: 191-6. PMID 24295383 DOI: 10.1021/Nl403713B  0.01
2014 Sonn GA, Margolis DJ, Marks LS. Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urologic Oncology. 32: 903-11. PMID 24239473 DOI: 10.1016/j.urolonc.2013.08.006  0.01
2014 Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. European Urology. 65: 809-15. PMID 23523537 DOI: 10.1016/J.Eururo.2013.03.025  0.01
2014 Apavaloaie L, Page T, Marks LD. Romanian children's representations of negative and self-conscious emotions in a narrative story stem technique Europe's Journal of Psychology. 10: 318-335. DOI: 10.5964/Ejop.V10I2.704  0.01
2014 Alghafli Z, Hatch T, Marks L. Religion and relationships in Muslim families: A qualitative examination of devout married Muslim couples Religions. 5: 814-833. DOI: 10.3390/Rel5030814  0.01
2014 Marks LH. Behind closed doors: Pornographic uses of the Victorian Sexualities. 17: 159-175. DOI: 10.1177/1363460713511106  0.01
2014 White N, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed N, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons J, ... ... Marks L, et al. Erratum: Diffusion-Weighted imaging in cancer: Physical foundations and applications of restriction spectrum imaging (Cancer Research (2014) 74 (4638-4652)) Cancer Research. 74: 6733. DOI: 10.1158/0008-5472.Can-14-2893  0.01
2014 Ringe E, Van Duyne RP, Marks LD. Correlated structure-optical properties studies of plasmonic nanoparticles Journal of Physics: Conference Series. 522. DOI: 10.1088/1742-6596/522/1/012006  0.01
2014 Thomas KA, Marks L. Action!: Student-Generated Videos in Social Work Education Journal of Technology in Human Services. 32: 254-274. DOI: 10.1080/15228835.2014.922912  0.01
2014 Masango SS, Peng L, Marks LD, Van Duyne RP, Stair PC. Nucleation and growth of silver nanoparticles by AB and ABC-type atomic layer deposition Journal of Physical Chemistry C. 118: 17655-17661. DOI: 10.1021/Jp504067C  0.01
2014 Wen J, Lin Y, Wu Z, Poeppelmeier KR, Marks LD. Direct observation of atomic surface structures of CeO2 nanoparticles Microscopy and Microanalysis. 20: 1918-1919. DOI: 10.1017/S1431927614011325  0.01
2014 Miao J, Chen CC, Scott MC, Ercius P, Zhu C, Mecklenburg M, White ER, Chiu CY, Regan BC, Huang Y, Marks LD, Dahmen U. Three-dimensional imaging of dislocations and defects in materials at atomic resolution using electron tomography Microscopy and Microanalysis. 20: 1062-1063. DOI: 10.1017/S143192761400703X  0.01
2014 Allen LJ, Brown HG, Alfonso AJD, Ciston J, Lin Y, Marks LD. Modeling secondary electron imaging at atomic resolution using a focused coherent electron probe Microscopy and Microanalysis. 20: 82-83. DOI: 10.1017/S143192761400213X  0.01
2014 Marks L, Gałaogonekzka D, Krzymińska J, Nita M, Stachowicz-Rybka R, Witkowski A, Woronko B, Dobosz S. Marine transgressions during Eemian in northern Poland: A high resolution record from the type section at Cierpieogonekta Quaternary International. 328: 45-49. DOI: 10.1016/j.quaint.2013.12.007  0.01
2014 Rychel J, Karasiewicz MT, Krześlak I, Marks L, Noryśkiewicz B, Woronko B. Paleogeography of the environment in north-eastern Poland recorded in an Eemian sedimentary basin, based on the example of the Jałówka site Quaternary International. 328: 60-73. DOI: 10.1016/j.quaint.2013.09.018  0.01
2014 Welc F, Marks L. Climate change at the end of the Old Kingdom in Egypt around 4200BP: New geoarchaeological evidence Quaternary International. 324: 124-133. DOI: 10.1016/j.quaint.2013.07.035  0.01
2014 Le J, Lieu P, Natarajan S, Dorey F, Margolis D, Huang J, Marks L. MP67-03 TARGETED PROSTATE BIOPSY: ARE SYSTEMATIC BIOPSIES STILL NECESSARY? Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2070  0.01
2014 Partin A, Klein E, Marks L, Gee J, Troyer D, Mangold L, Christ K, Bigley J, Van Neste L, Epstein J. MP63-14 MULTICENTER VALIDATION STUDY OF A TISSUE METHYLATION ASSAY TO PREDICT HISTOPATHOLOGICALLY CANCER-NEGATIVE REPEAT PROSTATE BIOPSIES Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1951  0.01
2014 Le J, Filson C, Margolis D, Marks L. V6-06 USE OF MRI/US FUSION FOR TARGETED PROSTATE BIOPSY IN ACTIVE SURVEILLANCE Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1869  0.01
2014 Le J, Stephenson S, Brugger M, Lu D, Sonn G, Lieu P, Natarajan S, Dorey F, Huang J, Margolis D, Reiter R, Marks L. MP46-03 MRI-US FUSION BIOPSY FOR IMPROVED PREDICTION OF WHOLE-ORGAN PROSTATE PATHOLOGY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1436  0.01
2014 Marks L, Keiding J, Wenzel T, Trumbull RB, Veksler I, Wiedenbeck M, Markl G. F, Cl, and S concentrations in olivine-hosted melt inclusions from mafic dikes in NW Namibia and implications for the environmental impact of the Paraná-Etendeka Large Igneous Province Earth and Planetary Science Letters. 392: 39-49. DOI: 10.1016/j.epsl.2014.01.057  0.01
2014 Wang H, Lu J, Marshall CL, Elam JW, Miller JT, Liu H, Enterkin JA, Kennedy RM, Stair PC, Poeppelmeier KR, Marks LD. In situ XANES study of methanol decomposition and partial oxidation to syn-gas over supported Pt catalyst on SrTiO3 nanocubes Catalysis Today. 237: 71-79. DOI: 10.1016/J.Cattod.2014.02.008  0.01
2014 Marks LV. Biotech-Pharma Collaboration-A Strategic Tool: Case Study of Centocor Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. 415-426. DOI: 10.1016/B978-0-12-404730-3.00029-4  0.01
2014 Johnson AM, Quezada BR, Marks LD, Stair PC. Influence of the metal oxide substrate structure on vanadium oxide monomer formation Topics in Catalysis. 57: 177-187. DOI: 10.1007/S11244-013-0174-3  0.01
2014 Williams C, Marks LR, Bannis B. Nurturing hope and resilience: Connecting with at-risk middle school students using rap therapy Youth and Adversity: Psychology and Influences of Child and Adolescent Resilience and Coping. 307-330.  0.01
2014 Taylor K, Mazur L, Chera B, Adams R, Mosaly P, Jackson M, Marks L. Application of "A3 thinking" to operational improvements in radiation oncology Iie Annual Conference and Expo 2014. 203-212.  0.01
2014 Marks LU. Enfolding-unfolding aesthetics, or the unthought at the heart of wood Technology and Desire: the Transgressive Art of Moving Images. 151-162.  0.01
2013 Mesko S, Banerjee R, Huang J, Jeffrey Demanes D, Marks LS. Quantifying the ki-67 heterogeneity profile in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 73. PMID 28137102 DOI: 10.1200/jco.2013.31.6_suppl.73  0.01
2013 Marks LA, Van Parys C, Coppens M, Herregods L. Awareness of dental practitioners to cope with a medical emergency: a survey in Belgium. International Dental Journal. 63: 312-6. PMID 24716245 DOI: 10.1111/idj.12046  0.01
2013 Kamrava M, Chung M, Mesko S, Wang J, Raman S, Margolis D, Marks L, Kupelian P. Correlation of Quantitative Diffusion-Weighted and Dynamic Contrast-Enhanced MRI Parameters With NCCN Risk Group, Gleason Score, and Maximum Tumor Diameter in Prostate Cancer. Practical Radiation Oncology. 3: S4. PMID 24674560 DOI: 10.1016/j.prro.2013.01.015  0.01
2013 Mosaly PR, Mazur LM, Jones EL, Hoyle L, Zagar T, Chera BS, Marks LB. Quantifying the impact of cross coverage on physician's workload and performance in radiation oncology. Practical Radiation Oncology. 3: e179-86. PMID 24674416 DOI: 10.1016/J.Prro.2013.02.007  0.01
2013 Mazur LM, Mosaly PR, Hoyle LM, Jones EL, Marks LB. Subjective and objective quantification of physician's workload and performance during radiation therapy planning tasks. Practical Radiation Oncology. 3: e171-7. PMID 24674415 DOI: 10.1016/J.Prro.2013.01.001  0.01
2013 Church JA, Adams RD, Hendrix LH, Holmes JA, Marks LB, Chen RC. National study to determine the comfort levels of radiation therapists and medical dosimetrists to report errors. Practical Radiation Oncology. 3: e165-70. PMID 24674414 DOI: 10.1016/j.prro.2012.12.001  0.01
2013 Zoellner LA, Bedard-Gilligan MA, Jun JJ, Marks LH, Garcia NM. The Evolving Construct of Posttraumatic Stress Disorder (PTSD): DSM-5 Criteria Changes and Legal Implications. Psychological Injury and Law. 6: 277-289. PMID 24470838 DOI: 10.1007/S12207-013-9175-6  0.01
2013 Cherry KE, Marks LD, Benedetto T, Sullivan MC, Barker A. Perceptions of Longevity and Successful Aging in Very Old Adults. Journal of Religion, Spirituality & Aging. 25. PMID 24353480 DOI: 10.1080/15528030.2013.765368  0.01
2013 Miao J, Chen CC, Zhu C, Scott MC, White ER, Chiu CY, Regan BC, Huang Y, Marks LD. Miao et al. reply. Nature. 503: E1-2. PMID 24256806 DOI: 10.1038/Nature12661  0.01
2013 Miller B, Marks LA, Koller JM, Newman BJ, Bretthorst GL, Black KJ. Prolactin and fMRI response to SKF38393 in the baboon. Peerj. 1: e195. PMID 24255811 DOI: 10.7717/Peerj.195  0.01
2013 Marks LB, Adams RD, Pawlicki T, Blumberg AL, Hoopes D, Brundage MD, Fraass BA. Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary. Practical Radiation Oncology. 3: 149-156. PMID 24175002 DOI: 10.1016/j.prro.2012.11.010  0.01
2013 Lin Y, Wen J, Hu L, Kennedy RM, Stair PC, Poeppelmeier KR, Marks LD. Synthesis-dependent atomic surface structures of oxide nanoparticles. Physical Review Letters. 111: 156101. PMID 24160614 DOI: 10.1103/Physrevlett.111.156101  0.01
2013 Marks LE, Mulvenna CM. Synesthesia, at and near its borders. Frontiers in Psychology. 4: 651. PMID 24133467 DOI: 10.3389/Fpsyg.2013.00651  0.01
2013 Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, Barriger RB, Moreno-Jiménez M, Kim TH, Ramella S, Everitt S, Rengan R, Marks LB, De Ruyck K, Warner A, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 87: 690-6. PMID 24035329 DOI: 10.1016/j.ijrobp.2013.07.029  0.01
2013 Albertsen PC, Marks LS. MRI before prostate biopsy--yes or no? The Journal of Urology. 190: 1978-80. PMID 23994537 DOI: 10.1016/j.juro.2013.08.050  0.01
2013 Higginson DS, Sahgal A, Lawrence MV, Moyer S, Stefanescu M, Willson AK, Qaqish B, Zanation A, Marks LB, Garg S, Chera BS. External beam radiotherapy for head and neck cancers is associated with increased variability in retinal vascular oxygenation. Plos One. 8: e69657. PMID 23936342 DOI: 10.1371/Journal.Pone.0069657  0.01
2013 Marks LR, Davidson BA, Knight PR, Hakansson AP. Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. Mbio. 4. PMID 23882016 DOI: 10.1128/Mbio.00438-13  0.01
2013 Kelsey CR, Higgins KA, Peterson BL, Chino JP, Marks LB, D'Amico TA, Varlotto JM. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data. The Journal of Thoracic and Cardiovascular Surgery. 146: 768-773.e1. PMID 23856204 DOI: 10.1016/j.jtcvs.2013.05.041  0.01
2013 Bortfeld T, Marks LB. Hype cycle in radiation oncology. International Journal of Radiation Oncology, Biology, Physics. 86: 819-21. PMID 23845838 DOI: 10.1016/j.ijrobp.2013.03.027  0.01
2013 Marks LB. Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy: in regard to Prabhu et al. International Journal of Radiation Oncology, Biology, Physics. 86: 808. PMID 23845830 DOI: 10.1016/j.ijrobp.2013.03.041  0.01
2013 Jean YY, Ribe EM, Pero ME, Moskalenko M, Iqbal Z, Marks LJ, Greene LA, Troy CM. Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death. The Biochemical Journal. 455: 15-25. PMID 23815625 DOI: 10.1042/Bj20130556  0.01
2013 Shin YJ, Ringe E, Personick ML, Cardinal MF, Mirkin CA, Marks LD, Van Duyne RP, Hersam MC. Centrifugal shape sorting and optical response of polyhedral gold nanoparticles. Advanced Materials (Deerfield Beach, Fla.). 25: 4023-7. PMID 23788292 DOI: 10.1002/Adma.201301278  0.01
2013 Ewart L, Milne A, Adkins D, Benjamin A, Bialecki R, Chen Y, Ericsson AC, Gardner S, Grant C, Lengel D, Lindgren S, Lowing S, Marks L, Moors J, Oldman K, et al. A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions. Journal of Pharmacological and Toxicological Methods. 68: 30-43. PMID 23665080 DOI: 10.1016/j.vascn.2013.04.008  0.01
2013 Marks LR, Clementi EA, Hakansson AP. Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET. Plos One. 8: e63158. PMID 23650551 DOI: 10.1371/Journal.Pone.0063158  0.01
2013 Marks LS. Editorial comment. The Journal of Urology. 190: 501. PMID 23643904 DOI: 10.1016/j.juro.2013.02.3241  0.01
2013 Marks L, Weatherly H, Mason A. Prioritizing investment in public health and health equity: what can commissioners do? Public Health. 127: 410-8. PMID 23632139 DOI: 10.1016/j.puhe.2013.01.027  0.01
2013 Zagar TM, Marks LB. Breast cancer: risk of heart disease after radiotherapy-cause for concern. Nature Reviews. Clinical Oncology. 10: 310-2. PMID 23609314 DOI: 10.1038/nrclinonc.2013.59  0.01
2013 Marks L, Beard E, Cobey D, Moore N, Motyer V, Valentin JP, Ewart L. An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability. Journal of Pharmacological and Toxicological Methods. 68: 123-36. PMID 23542059 DOI: 10.1016/j.vascn.2013.03.006  0.01
2013 Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. European Urology. 64: 544-52. PMID 23537686 DOI: 10.1016/j.eururo.2013.03.030  0.01
2013 Chen CC, Zhu C, White ER, Chiu CY, Scott MC, Regan BC, Marks LD, Huang Y, Miao J. Three-dimensional imaging of dislocations in a nanoparticle at atomic resolution. Nature. 496: 74-7. PMID 23535594 DOI: 10.1038/Nature12009  0.01
2013 Ringe E, Sharma B, Henry AI, Marks LD, Van Duyne RP. Single nanoparticle plasmonics. Physical Chemistry Chemical Physics : Pccp. 15: 4110-29. PMID 23420338 DOI: 10.1039/C3Cp44574G  0.01
2013 Kamrava M, Chung MP, Kayode O, Wang J, Marks L, Kupelian P, Steinberg M, Park SJ, Demanes DJ. Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment. Brachytherapy. 12: 434-41. PMID 23406987 DOI: 10.1016/j.brachy.2012.09.002  0.01
2013 Palatinus L, Jacob D, Cuvillier P, Klementová M, Sinkler W, Marks LD. Structure refinement from precession electron diffraction data. Acta Crystallographica. Section a, Foundations of Crystallography. 69: 171-88. PMID 23403968 DOI: 10.1107/S010876731204946X  0.01
2013 Liao Y, Marks LD. Reduction of electron channeling in EDS using precession. Ultramicroscopy. 126: 19-22. PMID 23376402 DOI: 10.1016/J.Ultramic.2012.11.007  0.01
2013 Brewer JM, Shavit AY, Shepard TG, Veldhuizen MG, Parikh R, Marks LE. Identification of gustatory-olfactory flavor mixtures: effects of linguistic labeling. Chemical Senses. 38: 305-13. PMID 23329730 DOI: 10.1093/Chemse/Bjs142  0.01
2013 Kelsey CR, Jackson IL, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoin. Clinical Lung Cancer. 14: 267-74. PMID 23313170 DOI: 10.1016/J.Cllc.2012.10.006  0.01
2013 Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective α(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. The Journal of Urology. 189: S122-8. PMID 23234617 DOI: 10.1016/j.juro.2012.11.020  0.01
2013 Loeb S, Sokoll LJ, Broyles DL, Bangma CH, van Schaik RH, Klee GG, Wei JT, Sanda MG, Partin AW, Slawin KM, Marks LS, Mizrahi IA, Shin SS, Cruz AB, Chan DW, et al. Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration. The Journal of Urology. 189: 1702-6. PMID 23206426 DOI: 10.1016/J.Juro.2012.11.149  0.01
2013 Liao Y, Hoffman E, Wimmer M, Fischer A, Jacobs J, Marks L. CoCrMo metal-on-metal hip replacements. Physical Chemistry Chemical Physics : Pccp. 15: 746-56. PMID 23196425 DOI: 10.1039/C2Cp42968C  0.01
2013 Trihandini I, Wiradidjaja Adiwoso A, Erri Astoeti T, Marks L. Oral health condition and treatment needs among young athletes with intellectual disabilities in Indonesia. International Journal of Paediatric Dentistry / the British Paedodontic Society [and] the International Association of Dentistry For Children. 23: 408-14. PMID 23163957 DOI: 10.1111/ipd.12010  0.01
2013 Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, Dorey FJ, Marks LS. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. The Journal of Urology. 189: 86-91. PMID 23158413 DOI: 10.1016/J.Juro.2012.08.095  0.01
2013 Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Current Opinion in Urology. 23: 43-50. PMID 23138468 DOI: 10.1097/Mou.0B013E32835Ad3Ee  0.01
2013 Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, et al. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. European Urology. 63: 201-9. PMID 22854248 DOI: 10.1016/J.Eururo.2012.07.030  0.01
2013 Kasivisvanathan V, Moore C, Eggener S, Emberton M, Futterer J, Gill I, Grubb R, Hadaschik B, Klotz L, Margolis D, Marks L, Melamed J, Oto A, Palmer S, Pinto P, et al. 138 Standards in reporting of MRI-targeted prostate biopsies (START): Recommendations from an international working party European Urology Supplements. 12: e138-e139. DOI: 10.1016/S1569-9056(13)60627-2  0.01
2013 Sonn G, Chang E, Natarajan S, Margolis D, Macairan M, Lieu P, Huang J, Hu J, Marks L. 1338 USE OF AN ELECTRONIC TRACKING SYSTEM FOR REPEAT BIOPSY OF PRIOR POSITIVE SITES IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.03.049  0.01
2013 Hu J, Chang E, Sonn G, Natarajan S, Margolis D, Macairan M, Lieu P, Huang J, Marks L. 1499 TARGETED BIOPSY FINDINGS IN SELECTION OF MEN FOR ACTIVE SURVEILLANCE: DO EPSTEIN CRITERIA STILL APPLY? Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2978  0.01
2013 Sonn G, Natarajan S, Margolis D, Chang E, Macairan M, Lieu P, Huang J, Dorey F, Marks L. 1473 PROSPECTIVE EVALUATION OF MRI-ULTRASOUND FUSION BIOPSY TO DIAGNOSE PROSTATE CANCER IN MEN WITH PRIOR NEGATIVE BIOPSIES Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2938  0.01
2013 Sonn G, Natarajan S, Margolis D, Chang E, Macairan M, Lieu P, Huang J, Dorey F, Marks L. V1267 TARGETED BIOPSY WITH MRI-ULTRASOUND FUSION Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2621  0.01
2013 Moore C, Kasivisvanathan V, Eggener S, Emberton M, Futterer J, Gill I, Grubb R, Hadashick B, Klotz L, Margolis D, Marks L, Melamed J, Oto A, Palmer S, Pinto P, et al. 1251 THE START CONSORTIUM RECOMMENDATIONS FOR THE REPORTING OF MRI–TARGETED PROSTATE BIOPSIES Journal of Urology. 189. DOI: 10.1016/j.juro.2013.02.2605  0.01
2013 Sanda M, Wei J, Broyles D, Shin S, Partin A, Klee G, Bangma C, Slawin K, Marks L, Cruz A, Mizrahi I, Chan D, Sokoll L, van Schaik RH, Loeb S, et al. 2055 PROSTATE HEALTH INDEX (PHI) FOR REDUCING OVERDETECTION OF INDOLENT PROSTATE CANCER AND UNNECESSARY BIOPSY WHILE IMPROVING DETECTION OF AGGRESSIVE CANCERS Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.2474  0.01
2013 Kamrava M, Chang E, Dorey F, Kupelian P, Marks L. Do Targeted Ultrasound/MRI Fusion Biopsies Significantly Change Maximum Prostate Gleason Score Compared With Systematic Biopsies? International Journal of Radiation Oncology*Biology*Physics. 87: S23-S24. DOI: 10.1016/J.Ijrobp.2013.06.066  0.01
2013 Kamrava M, Mesko S, Banerjee R, Raman S, Marks L, Demanes DJ, Margolis D. Evaluating the Utility of a Multi-Parametric MRI-Based Cancer Suspicion Score in Defining Brachytherapy Focal Therapy Targets for Prostate Cancer Brachytherapy. 12: S33. DOI: 10.1016/J.BRACHY.2013.01.057  0.01
2012 Chung MP, Kayode O, Wang J, Park SJ, Marks LS, Demanes DJ, Kamrava M. Dosimetric comparison of targeted high-dose-rate brachytherapy versus whole gland treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 255. PMID 27968172 DOI: 10.1200/jco.2012.30.5_suppl.255  0.01
2012 Margolis D, Kumar D, Macairan ML, Narayanan R, Natarajan S, Gandhi N, Shaw G, Marks LS. Prostate MRI/ultrasound fusion and biopsy yield. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 206. PMID 27967934 DOI: 10.1200/Jco.2012.30.5_Suppl.206  0.01
2012 Lawrence MV, Saynak M, Fried DV, Bateman TA, Green RL, Hubbs JL, Jaszczak RJ, Wong TZ, Zhou S, Das SK, Marks LB. Assessing the impact of radiation-induced changes in soft tissue density ∕ thickness on the study of radiation-induced perfusion changes in the lung and heart. Medical Physics. 39: 7644-9. PMID 23231312 DOI: 10.1118/1.4766433  0.01
2012 Marks L, Adler N, Blom-Reukers H, Elhorst JH, Kraaijenhagen-Oostinga A, Vanobbergen J. Ethics on the dental treatment of patients with mental disability: results of a Netherlands - Belgium survey. The Journal of Forensic Odonto-Stomatology. 30: 21-8. PMID 23221263  0.01
2012 Ringe E, Zhang J, Langille MR, Mirkin CA, Marks LD, Van Duyne RP. Correlating the structure and localized surface plasmon resonance of single silver right bipyramids. Nanotechnology. 23: 444005. PMID 23080080 DOI: 10.1088/0957-4484/23/44/444005  0.01
2012 Marks L. "We see what we seek": A rejoinder to the responses of Amato, Eggebeen, and Osborne. Social Science Research. 41: 784-5. PMID 23017849 DOI: 10.1016/J.Ssresearch.2012.05.001  0.01
2012 Marks L. Same-sex parenting and children's outcomes: A closer examination of the American psychological association's brief on lesbian and gay parenting. Social Science Research. 41: 735-51. PMID 23017844 DOI: 10.1016/J.Ssresearch.2012.03.006  0.01
2012 Marks LR, Reddinger RM, Hakansson AP. High levels of genetic recombination during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae. Mbio. 3. PMID 23015736 DOI: 10.1128/Mbio.00200-12  0.01
2012 Natarajan S, Culjat M, Singh R, Ennis D, Marks L, Grundfest WS. 3D reconstruction and image fusion using transurethral ultrasound Ieee International Ultrasonics Symposium, Ius. 138-141. DOI: 10.1109/ULTSYM.2012.0034  0.01
2012 Chun F, Hansen J, De La Taille A, Van Poppel H, Marberger M, Stenzl A, Mulders P, Huland H, Abbou C, Stillebroer A, Van Gils M, Schalken J, Fradet Y, Marks L, Ellis W, et al. 911 Biopsy-specific PCA3-based prostate biopsy nomograms are highly accurate European Urology Supplements. 11: e911-e911a. DOI: 10.1016/S1569-9056(12)60908-7  0.01
2012 Auprich M, Haese A, Taille ADL, Van PH, Marberger M, Mulders PFA, Abbou CC, Stillebroer AB, Van GPMQ, Schalken JA, Stenzl A, Fradet Y, Marks LS, Ellis W, Partin AW, et al. 263 Development of novel PCA3 cut-offs for initial and repeat biopsy using different statistical approaches within a US-European multi institutional cohort European Urology Supplements. 11. DOI: 10.1016/S1569-9056(12)60260-7  0.01
2012 Sonn GA, Natarajan S, Margolis D, Macairan M, Lieu P, Huang J, Dorey FJ, Marks LS. 2054 VALUE OF TARGETED BIOPSY IN DETECTING PROSTATE CANCER USING AN OFFICE-BASED MR-US FUSION DEVICE Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.2219  0.01
2012 Chun FK, Hansen J, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou C, Stillebroer AB, van Gils MP, Schalken JA, Fradet Y, Marks LS, Ellis W, et al. 1210 BIOPSY-SPECIFIC PCA3- BASED PROSTATE BIOPSY NOMOGRAMS ARE HIGHLY ACCURATE Journal of Urology. 187. DOI: 10.1016/J.JURO.2012.02.1499  0.01
2011 Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urologic Oncology. 29: 334-42. PMID 21555104 DOI: 10.1016/J.Urolonc.2011.02.014  0.01
2011 Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, et al. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. Journal of Translational Medicine. 9: 43. PMID 21504557 DOI: 10.1186/1479-5876-9-43  0.01
2011 Catalona WJ, Partin AW, Sanda MG, Wei JT, Klee GG, Bangma CH, Slawin KM, Marks LS, Loeb S, Broyles DL, Shin SS, Cruz AB, Chan DW, Sokoll LJ, Roberts WL, et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. The Journal of Urology. 185: 1650-5. PMID 21419439 DOI: 10.1016/J.Juro.2010.12.032  0.01
2011 Auprich M, Haese A, De LTA, Van Poppel H, Marberger M, Abbou C, Stenzl A, Mulders P, Schalken J, Huland H, Stillebroer A, Van GP, Fradet Y, Marks L, Ellis W, et al. 641 CRITICAL ASSESSMENT OF URINARY PROSTATE CANCER GENE 3 (PCA3) IN THE PREDICTION OF AGGRESSIVE PROSTATE CANCER (GLEASON score ≥ 7) AT BIOPSY European Urology Supplements. 10: 207. DOI: 10.1016/S1569-9056(11)60630-1  0.01
2011 Auprich M, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou C, Stillebroer AB, van Gils MP, Schalken JA, Fradet Y, Marks LS, de la Taille A, Ellis W, Partin AW, et al. 2320 INITIAL AND REPEAT PROSTATE BIOPSY: COMPARATIVE PERFORMANCE ANALYSIS OF PSA, %FPSA, PROSTATE VOLUME AND URINARY PCA3 INCLUDING DEVELOPMENT OF NOVEL PCA3 CUT-OFF THRESHOLDS Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2567  0.01
2011 Marks L, Natarajan S, Margolis D, Huang J, Kumar D, Narayanan R, Bentley R, Macairan ML, Lieu P. 2316 ARTEMIS: AN OFFICE-BASED DEVICE FOR MRI FUSION AND TARGETED PROSTATE BIOPSY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2562  0.01
2011 Auprich M, Haese A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou C, Stillebroer AB, van Gils MP, Schalken JA, Fradet Y, Marks LS, de la Taille A, Ellis W, et al. 987 CRITICAL ASSESSMENT OF URINARY PROSTATE CANCER GENE 3 (PCA3) IN THE PREDICTION OF AGGRESSIVE PROSTATE CANCER (GLEASON SCORE ≥ 7) AT BIOPSY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1019  0.01
2011 Catalona WJ, Sanda MG, Wei JT, Klee GG, Bangma CH, Slawin KM, Marks LS, Loeb S, Broyles DL, Shin SS, Cruz AB, Mizrahi IA, Chan DW, Sokoll LJ, Roberts WL, et al. 982 Evaluation Of The Prostate Health Index (Phi)1 In The 2 To 4, And 4 To 10 Ng/Ml Psa Ranges: Results From A Multi-Site, Prospective, Clinical Evaluation The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1014  0.01
2010 Gittelman MC, Marks LS, Hill LA, Volinn W, Hoel G. Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies. Open Access Journal of Urology. 3: 1-5. PMID 24198629 DOI: 10.2147/OAJU.S15333  0.01
2010 Marks LS, Huang J. Words of wisdom. Re: copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. European Urology. 57: 727-8. PMID 20965042 DOI: 10.1016/j.eururo.2010.01.028  0.01
2010 Marks LS. Editorial comment. Urology. 75: 453. PMID 20152509 DOI: 10.1016/j.urology.2009.04.020  0.01
2010 Marks L, Ward A, Gardi L, Bentley R, Kumar D, Gupta S, Macairan ML, Fenster A. 2141 TRACKING OF PROSTATE BIOPSY SITES USING A 3D ULTRASOUND DEVICE (ARTEMIS) Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.2242  0.01
2010 Catalona WJ, Sanda MG, Wei JT, Klee GG, Slawin KM, Marks LS, Bangma CH, Chan DW, Sokoll LJ, Roberts WL, Schaik Rv, Broyles DL, Cruz AB, Le BV, Mizrahi IA, et al. 137 Evaluation Of [-2]Propsa In Combination With Psa And Free Psa, Using The Beckman Coulter Access Immunoassay Systems, For Identifying Patients With Aggressive Prostate Cancer. A Multi-Center Prospective Clinical Evaluation The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.189  0.01
2010 Marks L, Weber A, Rittenhouse H, Macairan ML, Yee S, Bostwick D. 805 EFFECTS OF PROSTATITIS ON SERUM PSA AND URINARY PCA3 GENE SCORE Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.1481  0.01
2010 Chun FK, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PFA, Huland H, Abbou CC, Stillebroer AB, van Gils MPMQ, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, et al. Reply to Juan Morote's Letter to the Editor re: Felix K. Chun, Alexandre de la Taille, Hendrik van Poppel, et al. Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram. Eur Urol 2009;56:659-68 European Urology. 57: e2-e3. DOI: 10.1016/J.Eururo.2009.09.042  0.01
2009 Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study. Urology. 74: 1318-22. PMID 19815265 DOI: 10.1016/j.urology.2009.06.072  0.01
2009 Marks LS, Kaplan SA. Should testosterone replacement be given to men with large prostates? The Journal of Urology. 182: 2109-11. PMID 19758636 DOI: 10.1016/j.juro.2009.08.101  0.01
2009 Marks LS. Words of wisdom. Re: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. European Urology. 55: 750-1. PMID 19650234 DOI: 10.1016/J.EURURO.2008.11.048  0.01
2009 Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C. Testosterone and prostate cancer: revisiting old paradigms. European Urology. 56: 48-56. PMID 19375844 DOI: 10.1016/j.eururo.2009.03.088  0.01
2009 Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. The Journal of Urology. 181: 2634-40. PMID 19371887 DOI: 10.1016/j.juro.2009.02.034  0.01
2009 Chun FK, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Stillebroer AB, van Gils MP, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, et al. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram. European Urology. 56: 659-67. PMID 19304372 DOI: 10.1016/j.eururo.2009.03.029  0.01
2009 Marks LS, Macairan M, Keltner L, Christopherson J, Briggs B, Wang S, Madsen T, Liu J, Bouchard G. LIGHT-ACTIVATED DRUG THERAPY FOR BPH The Journal of Urology. 181: 704-705. DOI: 10.1016/S0022-5347(09)61970-4  0.01
2009 Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. RAPID RESPONSE OF IRRITATIVE AND OBSTRUCTIVE URINARY SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA TO TREATMENT WITH SILODOSIN IN 2 RANDOMIZED STUDIES The Journal of Urology. 181: 694. DOI: 10.1016/S0022-5347(09)61943-1  0.01
2009 Meng J, Mostaghel EA, Marks LS, Nelson PS. THE IMPACT OF ANDROGEN DEFICIENCY ON TIGHT JUNCTION ARCHITECTURE AND PROSTATE INFLAMMATION Journal of Urology. 181: 506-506. DOI: 10.1016/S0022-5347(09)61428-2  0.01
2009 Lin DW, Marks LS, Morton RA, Rodriguez D. POSITIVE FRACTURE REDUCTION TRIAL OF TOREMIFENE 80 MG IN MEN ON ADT DEMONSTRATES SIGNIFICANT FRACTURE RISK IN UNTREATED PLACEBO GROUP Journal of Urology. 181: 229-229. DOI: 10.1016/S0022-5347(09)60653-4  0.01
2009 Marks LS. Reply Urology. 74: 1323-1324. DOI: 10.1016/J.UROLOGY.2009.07.1223  0.01
2008 Marks LS, Mostaghel EA, Nelson PS. Prostate tissue androgens: history and current clinical relevance. Urology. 72: 247-54. PMID 18502483 DOI: 10.1016/j.urology.2008.03.033  0.01
2008 Marks LS. Editorial comment. The Journal of Urology. 179: 1744-5. PMID 18343450 DOI: 10.1016/j.juro.2008.01.214  0.01
2008 Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, Ellis WJ, Marks LS, Fradet Y, Rittenhouse H, Groskopf J. PCA3: a molecular urine assay for predicting prostate biopsy outcome. The Journal of Urology. 179: 1587-92. PMID 18295257 DOI: 10.1016/j.juro.2007.11.038  0.01
2008 Slawin KM, Marks LS, McVary KT, Levitt JM, Lamb DJ, Macairan M, Gago B, Broyles DL, Mizrahi IA. SERUM LEVELS OF BPSA EXHIBIT A TRANSIENT DRAMATIC “SPIKE” IN THE EARLY WEEKS AFTER INITIATION OF 5 ALPHA REDUCTASE THERAPY (5ARI) Journal of Urology. 179: 702-702. DOI: 10.1016/S0022-5347(08)62047-9  0.01
2008 Marks LS, Roehrborn CG, Marberger M, Wilson TH, Rittmaster RS. IS PSA INFLUENCED BY TESTOSTERONE LEVELS IN AGING MEN? Journal of Urology. 179: 301-301. DOI: 10.1016/S0022-5347(08)60877-0  0.01
2008 Marks LS. Does testosterone administration affect the prostate? Current Sexual Health Reports. 5: 190-196. DOI: 10.1007/s11930-008-0034-5  0.01
2007 Marks LS, Roehrborn CG, Wolford E, Wilson TH. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response. The Journal of Urology. 177: 1408-13. PMID 17382742 DOI: 10.1016/j.juro.2006.11.095  0.01
2007 Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM, Cancio AT, Desaulniers M, Ellis WJ, Rittenhouse H, Groskopf J. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology. 69: 532-5. PMID 17382159 DOI: 10.1016/j.urology.2006.12.014  0.01
2007 Plante MK, Marks LS, Anderson R, Amling C, Rukstalis D, Badlani G, Getlin L, Vang E. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia. The Journal of Urology. 177: 1030-5; discussion 1. PMID 17296405 DOI: 10.1016/j.juro.2006.10.024  0.01
2007 Groskopf J, Blase A, Koo S, Deras I, Aubin S, Rittenhouse H, Marks L, Fradet Y. 102 THE PCA3 SCORE IS INDEPENDENT OF PROSTATE GLAND VOLUME, AND CAN SYNERGIZE WITH OTHER PATIENT INFORMATION FOR PREDICTING BIOPSY OUTCOME European Urology Supplements. 6: 48. DOI: 10.1016/S1569-9056(07)60101-8  0.01
2007 Groskopf J, Deras IL, Blase A, Aubin SM, Koo S, Fradet Y, Marks LS, Rittenhouse H. 1709: The PCA3 Score is Independent of Prostate Gland Volume, and Can Synergize with other Patient Information for Predicting Biopsy Outcome Journal of Urology. 177: 568-568. DOI: 10.1016/s0022-5347(18)31897-4  0.01
2006 Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Jama. 296: 2351-61. PMID 17105798 DOI: 10.1001/jama.296.19.2351  0.01
2006 Veltri RW, Khan MA, Marlow C, Miller MC, Mikolajczyk SD, Kojima M, Partin AW, Marks LS. Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer. Urology. 68: 898-904. PMID 17070389 DOI: 10.1016/j.urology.2006.05.008  0.01
2006 Marks LS, Roehrborn CG, Andriole GL. Prevention of benign prostatic hyperplasia disease. The Journal of Urology. 176: 1299-306. PMID 16952616 DOI: 10.1016/j.juro.2006.06.022  0.01
2006 Marks LS, Hess DL, Dorey FJ, Macairan ML. Prostatic tissue testosterone and dihydrotestosterone in African-American and white men. Urology. 68: 337-41. PMID 16904448 DOI: 10.1016/j.urology.2006.03.013  0.01
2006 Marks LS, Andriole GL, Fitzpatrick JM, Schulman CC, Roehrborn CG. The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. The Journal of Urology. 176: 868-74. PMID 16890642 DOI: 10.1016/j.juro.2006.04.024  0.01
2006 Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, Brentano S, Mathis J, Pham J, Meyer T, Cass M, Hodge P, Macairan ML, Marks LS, Rittenhouse H. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clinical Chemistry. 52: 1089-95. PMID 16627561 DOI: 10.1373/clinchem.2005.063289  0.01
2006 Marberger M, Roehrborn CG, Marks LS, Wilson T, Rittmaster RS. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 91: 1323-8. PMID 16434455 DOI: 10.1210/jc.2005-1947  0.01
2006 Marks LS, Nelson PS. Testosterone supplementation and the prostate: A review of the safety issue Current Opinion in Endocrinology and Diabetes. 13: 272-277. DOI: 10.1097/01.med.0000224808.54566.13  0.01
2006 Groskopf J, Aubin SJ, Deras I, Blase A, Bodrug S, Brentano S, Clark C, Rittenhouse H, Macairan M, Marks L. SPECIFICITY OF THE APTIMA® PCA3 ASSAY FOR PROSTATE CANCER European Urology Supplements. 5: 240. DOI: 10.1016/S1569-9056(06)60875-0  0.01
2006 Roehrborn C, Wei J, Althof S, Marks L, Pasta D, Seftel A. DEMOGRAPHIC AND CLINICAL PARAMETERS ASSOCIATED WITH USE OF MEDICAL THERAPY AT ENROLMENT IN THE BPH REGISTRY AND PATIENT SURVEY European Urology Supplements. 5: 198. DOI: 10.1016/S1569-9056(06)60708-2  0.01
2006 Rosen RC, Marks LS, McVary KT, Roehrborn CG, O'Leary MP, Lue TF. 921: Association between Ejaculatory Dysfunction and Therapy Among Men Enrolled in the BPH Registry & Patient Survey Journal of Urology. 175: 298-299. DOI: 10.1016/S0022-5347(18)33157-4  0.01
2006 Marks LS, Mazer N, Hess DL, Nelson PS, Dorey FJ, Bostwick DG, Epstein JI, Veltri RW, Macairan ML, Partin AW. 691: Effects of Testosterone Administration on Prostate Tissues in Men with Adam Syndrome Journal of Urology. 175: 224-224. DOI: 10.1016/S0022-5347(18)32937-9  0.01
2006 Marks LS, Aubin SM, Deras IL, Brentano S, Blase A, Bodrug S, Macairan ML, Ko TY, Rittenhouse HG, Groskopf J. 540: Specificity of the Aptima® PCA3 Assay for Prostate Cancer Journal of Urology. 175: 175-176. DOI: 10.1016/s0022-5347(18)32786-1  0.01
2006 Mostaghel EA, Marks LS, Mazer N, Coleman I, Dumpit R, Nelson PS. 437: Quantitative Assessment of Prostate Gene Expression Changes Following Testosterone Supplementation Journal of Urology. 175: 142-142. DOI: 10.1016/s0022-5347(18)32693-4  0.01
2006 Marks LS. Use of 5α-reductase inhibitors to prevent benign prostatic hyperplasia disease Current Urology Reports. 7: 293-303. DOI: 10.1007/s11934-996-0009-x  0.01
2005 Zinner N, Tuttle J, Marks L. Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder World Journal of Urology. 23: 248-252. PMID 16096831 DOI: 10.1007/s00345-005-0507-3  0.01
2005 Baker SM, Brawley OW, Marks LS. Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology. 65: 1259-62. PMID 15922414 DOI: 10.1016/j.urology.2004.10.023  0.01
2005 Roehrborn C, Marks L, Wolford E, Wilson T. 287Value of the transition zone index in predicting changes in symptoms and maximum flow rate and risk of acute urinary retention and BPH-related surgery in men with symptomatic BPH European Urology Supplements. 4: 74. DOI: 10.1016/S1569-9056(05)80295-7  0.01
2005 Roehrborn C, Marks L, Wolford E, Wilson T. 12 The transition zone hypothesis in benign prostatic hyperplasia European Urology Supplements. 4: 5. DOI: 10.1016/S1569-9056(05)80022-3  0.01
2005 Marks LS, Wolford E, Wilson TG, Roehrborn CG. 1704: Ability of the Transition Zone Index to Predict Changes in Symptoms and Maximum Flow Rate in Men with BPH Treated with Placebo Versus Dutasteride Journal of Urology. 173: 462-462. DOI: 10.1016/S0022-5347(18)35826-9  0.01
2005 Marks LS, Wolford E, Wilson TG, Roehrborn CG. 1703: Transition Zone Hypothesis in Benign Prostatic Hyperplasia Journal of Urology. 173: 462-462. DOI: 10.1016/s0022-5347(18)35825-7  0.01
2005 Baker SM, Brawley OW, Marks LS. 894: “The Effects of Untreated Syphilis in the Negro Male, 1932-1972” A Closure Comes to the Tuskegee Study, 2004 Journal of Urology. 173: 242-242. DOI: 10.1016/s0022-5347(18)35050-x  0.01
2004 Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW. Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue. Urology. 64: 765-71. PMID 15491717 DOI: 10.1016/j.urology.2004.05.047  0.01
2004 Roehrborn CG, Marks LS, Fenter T, Freedman S, Tuttle J, Gittleman M, Morrill B, Wolford ET. Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia. Urology. 63: 709-15. PMID 15072886 DOI: 10.1016/j.urology.2004.01.001  0.01
2004 Sokoll LJ, Marks LS, Mikolajczyk SD, Bruzek DJ, Mohr P, Mangold LA, Rittenhouse HG, Chan DW, Partin AW. 1659: Effects of Finasteride and Saw Palmetto on BPSA, Propsa, and cPSA in Men with Benign Prostatic Hyperplasia Journal of Urology. 171: 438-439. DOI: 10.1016/S0022-5347(18)38867-0  0.01
2004 Marks LS, Mikolajczyk SD, Rittenhouse HG, Linton HJ, Evans CL, Macairan ML, Baker SM. 1658: Effects of Prostate Biopsy on PSA Isoforms in men With BPH and Cancer Journal of Urology. 171: 438-438. DOI: 10.1016/S0022-5347(18)38866-9  0.01
2004 Marks LS, Roehrborn CG, Rittmaster RS. 914: Duration of Dihydrotestosterone Suppression Following Discontinuation of Dutasteride: Implications for Missed Doses Journal of Urology. 171: 242-243. DOI: 10.1016/S0022-5347(18)38163-1  0.01
2004 Roehrborn CG, Marks LS, Fenter T, Barkin J, Freedman S, Gittelman M. 913: Long-Term Dutasteride Therapy Results in Continued Improvements in Symptoms and Peak Urinary Flow in Men with Symptomatic Benign Prostatic Hyperplasia Journal of Urology. 171: 242-242. DOI: 10.1016/S0022-5347(18)38162-X  0.01
2003 Marks LS. Luteinizing hormone-releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant. Urology. 62: 36-42. PMID 14706507 DOI: 10.1016/j.urology.2003.10.029  0.01
2003 Marks LS, Roehrborn CG, Gittelman M, Kim D, Forrest J, Jacobs S. First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia. Urology. 62: 888-93. PMID 14624914 DOI: 10.1016/S0090-4295(03)00657-5  0.01
2003 Marks LS. Treatment of men with minimally symptomatic benign prostatic hyperplasia--PRO: the argument in favor. Urology. 62: 781-3. PMID 14624893 DOI: 10.1016/S0090-4295(03)00779-9  0.01
2003 Linton HJ, Marks LS, Millar LS, Knott CL, Rittenhouse HG, Mikolajczyk SD. Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease. Clinical Chemistry. 49: 253-9. PMID 12560348 DOI: 10.1373/49.2.253  0.01
2003 Marks LS, Cheng PJ. Urology: Introduction Urology. 61: 1. DOI: 10.1016/S0090-4295(03)00114-6  0.01
2002 Veltri RW, Marks LS, Miller MC, Bales WD, Fan J, Macairan ML, Epstein JI, Partin AW. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism. Urology. 60: 617-22. PMID 12385921 DOI: 10.1016/S0090-4295(02)01838-1  0.01
2002 Marks LS, DiPaola RS, Nelson P, Chen S, Heber D, Belldegrun AS, Lowe FC, Fan J, Leaders FE, Pantuck AJ, Tyler VE. PC-SPES: herbal formulation for prostate cancer. Urology. 60: 369-75; discussion 3. PMID 12350462 DOI: 10.1016/S0090-4295(02)01913-1  0.01
2002 Mikolajczyk SD, Marks LS, Partin AW, Rittenhouse HG. Free prostate-specific antigen in serum is becoming more complex. Urology. 59: 797-802. PMID 12031356 DOI: 10.1016/S0090-4295(01)01605-3  0.01
2001 Marks LS, Hess DL, Dorey FJ, Luz Macairan M, Cruz Santos PB, Tyler VE. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology. 57: 999-1005. PMID 11337315 DOI: 10.1016/S0090-4295(00)01052-9  0.01
2001 Marks LS, Epstein JI, Partin AW. The role of prostate needle biopsy in evaluation of chemopreventive agents. Urology. 57: 191-3. PMID 11295625 DOI: 10.1016/S0090-4295(00)00972-9  0.01
2001 Partin AW, Marks LS. Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents. Urology. 57: 132-6. PMID 11295611 DOI: 10.1016/S0090-4295(00)00958-4  0.01
2000 Mikolajczyk SD, Millar LS, Marker KM, Wang TJ, Rittenhouse HG, Marks LS, Slawin KM. Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia. The Prostate. 45: 271-6. PMID 11074531 DOI: 10.1002/1097-0045(20001101)45:3<271::AID-PROS11>3.0.CO;2-T  0.01
2000 Mikolajczyk SD, Millar LS, Wang TJ, Rittenhouse HG, Wolfert RL, Marks LS, Song W, Wheeler TM, Slawin KM. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology. 55: 41-5. PMID 10654892 DOI: 10.1016/S0090-4295(99)00372-6  0.01
2000 MARKS LS, PARTIN AW, EPSTEIN JI, TYLER VE, SIMON I, MACAIRAN ML, CHAN TL, DOREY FJ, GARRIS JB, VELTRI RW, SANTOS PBC, STONEBROOK KA, deKERNION JB. EFFECTS OF A SAW PALMETTO HERBAL BLEND IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA Journal of Urology. 163: 1451-1456. DOI: 10.1016/S0022-5347(05)67641-0  0.01
1999 Marks LS, Duda C, Dorey FJ, Macairan ML, Santos PB. Treatment of erectile dysfunction with sildenafil. Urology. 53: 19-24. PMID 9886582 DOI: 10.1016/S0090-4295(98)00525-1  0.01
1999 Epstein JI, Partin AW, Shue M, Sherry ED, Marks LS. Histological Changes in Benign Prostate Biopsies Following Long-Term Finasteride Therapy for Prostatic Hyperplasia Journal of Urologic Pathology. 10: 87-96. DOI: 10.1385/JUP:10:2:87  0.01
1999 Epstein JI, Partin AW, Simon I, Kyprianou N, Hess DL, Prins G, Marks LS, Dorey FJ, Macairan ML, Santos PBC. Prostate Tissue Effects Of Saw Palmetto Extract In Men With Symptomatic Bph The Journal of Urology. 362. DOI: 10.1097/00005392-199904020-00450  0.01
1999 Marks LS, Partin AW, Dorey FJ, Gormley GJ, Epstein JI, Garris JB, Macairan ML, Shery ED, Santos PB, Stoner E, deKernion JB. Long-term effects of finasteride on prostate tissue composition Urology. 53: 574-580. DOI: 10.1016/S0090-4295(98)00567-6  0.01
1998 Pannek J, Marks LS, Pearson JD, Rittenhouse HG, Chan DW, Shery ED, Gormley GJ, Subong EN, Kelley CA, Stoner E, Partin AW. Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia. The Journal of Urology. 159: 449-53. PMID 9649261 DOI: 10.1016/S0022-5347(01)63946-6  0.01
1997 Marks LS, Dorey FJ, Macairan ML, Park C, deKernion JB. Three-dimensional ultrasound device for rapid determination of bladder volume. Urology. 50: 341-8. PMID 9301695 DOI: 10.1016/S0090-4295(97)00293-8  0.01
1997 Marks LS, Partin AW, Gormley GJ, Dorey FJ, Shery ED, Garris JB, Subong EN, Stoner E, deKernion JB. Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic Hyperplasia Journal of Urology. 157: 2171-2178. DOI: 10.1016/s0022-5347(01)64707-4  0.01
1996 Marks LS, Dorey FJ, Rhodes T, Shery ED, Rittenhouse H, Partin AW, deKernion JB. Serum Prostate Specific Antigen Levels after Transurethral Resection of Prostate: A Longitudinal Characterization in Men with Benign Prostatic Hyperplasia Journal of Urology. 156: 1035-1039. DOI: 10.1016/S0022-5347(01)65694-5  0.01
1995 Marks LS, Treiger B, Dorey FJ, Shery ED. Prostatic aperture resulting from visual laser ablation: classification system based on follow-up endoscopy. Journal of Endourology / Endourological Society. 9: 175-81. PMID 7543329 DOI: 10.1089/END.1995.9.175  0.01
1994 Marks LS, Treiger B, Dorey FJ, Fu YS, deKernion JB. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands. Urology. 44: 486-92. PMID 7524234 DOI: 10.1016/S0090-4295(94)80044-8  0.01
1993 Marks LS. Serial endoscopy following visual laser ablation of prostate (VLAP) Urology. 42: 66-71. PMID 7687080 DOI: 10.1016/0090-4295(93)90344-A  0.01
1992 Marks LS. Value of balloon dilation in treatment of youthful patients with prostatism. Urology. 39: 31-8. PMID 1370248 DOI: 10.1016/0090-4295(92)90037-W  0.01
1983 Marks LS, Maxwell MH, Smith RB, Cahill PJ, Kaufman JJ. Detection of renovascular hypertension: saralasin test versus renin determinations. The Journal of Urology. 116: 406-9. PMID 1053323 DOI: 10.1016/S0022-5347(17)58836-9  0.01
1980 Gillespie L, Ehrlich RM, Marks LS, Maxwell MH, Kaufman JJ. Use of saralasin to detect renovascular hypertension in childhood. Urology. 16: 453-6. PMID 7003900 DOI: 10.1016/0090-4295(80)90593-2  0.01
1980 Zawada ET, Maxwell MH, Marks LS, Lee DB, Kaufman JJ. The diagnostic and therapeutic uses of saralasin in renal transplant hypertension. The Journal of Urology. 123: 148-52. PMID 6986475 DOI: 10.1016/S0022-5347(17)55829-2  0.01
1979 Zawada ET, Dornfeld L, Maxwell M, Marks L, Kaufman JJ. Pheochromocytoma and vasodepressor response to saralasin. Annals of Internal Medicine. 91: 494-5. PMID 475193 DOI: 10.7326/0003-4819-91-3-494_3  0.01
1979 Walther PJ, Marks LS, Stern D, Smith RB. Renal metastasis of adenocarcinoma of the lung: massive hematuria managed by therapeutic embolization. The Journal of Urology. 122: 398-400. PMID 470021 DOI: 10.1016/S0022-5347(17)56429-0  0.01
1979 Marks LS, Maxwell MH. Tigerstedt and the discovery of renin. An historical note. Hypertension. 1: 384-8. PMID 396241 DOI: 10.1161/01.HYP.1.4.384  0.01
1979 Maxwell MH, Varady P, Zawada ET, Burkhalter JF, Waks U, Marks L. Maximal discrimination of renovascular from essential hypertension by the saralasin test. Clinical Science and Molecular Medicine. Supplement. 4: 297s-299s. PMID 282071 DOI: 10.1042/CS055297S  0.01
1978 Waks UA, Maxwell MH, Marks L, Zawada ET, Kaufman JJ. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients. Circulation. 57: 1165-70. PMID 639240 DOI: 10.1161/01.CIR.57.6.1165  0.01
1977 Marks LS, Maxwell MH, Kaufman JJ. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension. Annals of Internal Medicine. 87: 176-82. PMID 889198 DOI: 10.7326/0003-4819-87-2-176  0.01
1977 Marks LS, Maxwell MH, Gross C, Waks U, Kaufman JJ. Angiotensin blockade in renovascular hypertension: a controlled, prospective study. British Journal of Urology. 49: 181-8. PMID 334316 DOI: 10.1111/J.1464-410X.1977.TB04099.X  0.01
1977 Barajas L, Marks LS, Trygstad CW. Unilateral renal hypoplasia with associated venous anomaly and hypertension. A study of the juxtaglomerular cells. Virchows Archiv. a, Pathological Anatomy and Histology. 374: 169-82. PMID 141787 DOI: 10.1007/BF00432899  0.01
1977 Marks LS, Maxwell MH, Kaufman JJ. Non-renin-mediated renovascular hypertension: A new syndrome? Lancet (London, England). 1: 615-7. PMID 66424 DOI: 10.1016/S0140-6736(77)92054-2  0.01
1976 Marks LS, Maxwell MH, Varady PD, Lupu AN, Kaufman JJ. Renovascular hypertension: does the renal vein renin ratio predict operative results? The Journal of Urology. 115: 365-8. PMID 1263307 DOI: 10.1016/S0022-5347(17)59206-X  0.01
1976 Marks LS. Renal Artery Repair Jama. 236: 1972. DOI: 10.1001/JAMA.1976.03270180048021  0.01
1975 Marks LS, Maxwell MH, Kaufman JJ. Saralasin bolus test The Lancet. 306: 784-787. DOI: 10.1016/S0140-6736(75)80003-1  0.01
1974 Marks LS, Smith RB, Kaufman JJ. The renal hypertensive suspect with coexistent lesions. Urology. 4: 140-4. PMID 4855053 DOI: 10.1016/0090-4295(74)90324-0  0.01
1974 Marks LS, Brosman SA, Lindstrom RR, Fay R. Arteriography in penetrating renal trauma. Urology. 3: 18-22. PMID 4812892 DOI: 10.1016/S0090-4295(74)80051-8  0.01
1974 Marks LS. Vesicoureteral reflux from foreign body calculus in the bladder. The Journal of Urology. 112: 516-8. PMID 4416865 DOI: 10.1016/S0022-5347(17)59780-3  0.01
1973 Poutasse EF, Marks LS, Wisoff CP, Vinson AM, Wan AT. Renal vein renin determinations in hypertension: falsely negative tests. The Journal of Urology. 110: 371-4. PMID 4742170 DOI: 10.1016/S0022-5347(17)60222-2  0.01
1973 Marks LS, Poutasse EF. Hypertension from renal tuberculosis: operative cure predicted by renal vein renin. The Journal of Urology. 109: 149-51. PMID 4685720 DOI: 10.1016/S0022-5347(17)60375-6  0.01
Hide low-probability matches.